US20190262514A1 - Reduced-Pressure Systems, Dressings, And Methods Facilitating Separation Of Electronic And Clinical Component Parts - Google Patents
Reduced-Pressure Systems, Dressings, And Methods Facilitating Separation Of Electronic And Clinical Component Parts Download PDFInfo
- Publication number
- US20190262514A1 US20190262514A1 US16/367,600 US201916367600A US2019262514A1 US 20190262514 A1 US20190262514 A1 US 20190262514A1 US 201916367600 A US201916367600 A US 201916367600A US 2019262514 A1 US2019262514 A1 US 2019262514A1
- Authority
- US
- United States
- Prior art keywords
- pouch
- cover
- reduced
- absorbent
- pump
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 34
- 238000000926 separation method Methods 0.000 title description 20
- 230000002745 absorbent Effects 0.000 claims abstract description 153
- 239000002250 absorbent Substances 0.000 claims abstract description 153
- 239000007788 liquid Substances 0.000 claims abstract description 21
- 239000010410 layer Substances 0.000 claims description 97
- 238000007789 sealing Methods 0.000 claims description 77
- 239000012530 fluid Substances 0.000 claims description 43
- 230000008878 coupling Effects 0.000 claims description 31
- 238000010168 coupling process Methods 0.000 claims description 31
- 238000005859 coupling reaction Methods 0.000 claims description 31
- 239000000758 substrate Substances 0.000 claims description 25
- 238000004891 communication Methods 0.000 claims description 9
- 239000012790 adhesive layer Substances 0.000 claims description 4
- 210000001519 tissue Anatomy 0.000 description 78
- 239000000463 material Substances 0.000 description 56
- 206010052428 Wound Diseases 0.000 description 35
- 208000027418 Wounds and injury Diseases 0.000 description 34
- 230000001070 adhesive effect Effects 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 239000000853 adhesive Substances 0.000 description 10
- 239000000835 fiber Substances 0.000 description 9
- 239000002906 medical waste Substances 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 239000006260 foam Substances 0.000 description 8
- 230000008901 benefit Effects 0.000 description 6
- 210000000416 exudates and transudate Anatomy 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000004814 polyurethane Substances 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 238000003466 welding Methods 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 229920000954 Polyglycolide Polymers 0.000 description 3
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000000806 elastomer Substances 0.000 description 3
- 239000013536 elastomeric material Substances 0.000 description 3
- 239000010793 electronic waste Substances 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 238000005304 joining Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- -1 open-cell Polymers 0.000 description 3
- 239000004633 polyglycolic acid Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229920001084 poly(chloroprene) Polymers 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229920002725 thermoplastic elastomer Polymers 0.000 description 2
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002943 EPDM rubber Polymers 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229920000181 Ethylene propylene rubber Polymers 0.000 description 1
- RYECOJGRJDOGPP-UHFFFAOYSA-N Ethylurea Chemical compound CCNC(N)=O RYECOJGRJDOGPP-UHFFFAOYSA-N 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000459 Nitrile rubber Polymers 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001247 Reticulated foam Polymers 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 239000010796 biological waste Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000005489 elastic deformation Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229920005669 high impact polystyrene Polymers 0.000 description 1
- 239000004797 high-impact polystyrene Substances 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 229920002681 hypalon Polymers 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000010137 moulding (plastic) Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 238000009581 negative-pressure wound therapy Methods 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000005077 polysulfide Substances 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 150000008117 polysulfides Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Classifications
-
- A61M1/009—
-
- A61F13/05—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00068—Accessories for dressings specially adapted for application or removal of fluid, e.g. irrigation or drainage of wounds, under-pressure wound-therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0203—Adhesive plasters or dressings having a fluid handling member
- A61F13/0206—Adhesive plasters or dressings having a fluid handling member the fluid handling member being absorbent fibrous layer, e.g. woven or nonwoven absorbent pad, island dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0203—Adhesive plasters or dressings having a fluid handling member
- A61F13/0216—Adhesive plasters or dressings having a fluid handling member the fluid handling member being non absorbent, e.g. for use with sub- or over-pressure therapy, wound drainage or wound irrigation systems
-
- A61M1/0092—
-
- A61M1/0094—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/915—Constructional details of the pressure distribution manifold
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/96—Suction control thereof
- A61M1/962—Suction control thereof having pumping means on the suction site, e.g. miniature pump on dressing or dressing capable of exerting suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/96—Suction control thereof
- A61M1/964—Suction control thereof having venting means on or near the dressing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/98—Containers specifically adapted for negative pressure wound therapy
- A61M1/984—Containers specifically adapted for negative pressure wound therapy portable on the body
- A61M1/985—Containers specifically adapted for negative pressure wound therapy portable on the body the dressing itself forming the collection container
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
-
- A61M1/0088—
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49815—Disassembling
- Y10T29/49822—Disassembling by applying force
Definitions
- the present disclosure relates generally to medical treatment systems and, more particularly, but not by way of limitation, to reduced-pressure wound dressings, systems, and methods that facilitate the separation of clinical waste and electronics waste for efficient disposal.
- a reduced-pressure dressing for applying reduced pressure treatment to a tissue site includes an absorbent pouch and an electronics pouch.
- the absorbent pouch includes a manifold, an absorbent layer, and a first cover.
- the manifold layer is adapted to deliver reduced pressure to the tissue site, the absorbent layer is in fluid communication with the manifold layer to absorb liquid from at least one of the manifold layer and the tissue site, and the first cover is positioned over the absorbent layer and the manifold layer to maintain the reduced pressure at the tissue site.
- the electronics pouch is removably coupled to the absorbent pouch, and includes a pump and a second cover.
- the pump is adapted to provide fluid communication to the tissue site through at least one of the absorbent layer and the manifold layer, and the second cover has a first electronics cover and a second electronics cover.
- the second electronics cover is coupled to the first electronics cover and the pump is positioned between the first electronics cover and the second electronics cover.
- the reduced-pressure dressing includes an electronics pouch removably coupled to an absorbent pouch.
- the absorbent pouch includes a tissue manifold layer, an absorbent layer in fluid communication with the tissue manifold layer, and a first cover.
- the method comprises pulling the electronics pouch to separate electronics pouch from the absorbent pouch along a weakened coupling between the electronics pouch and the absorbent pouch.
- a reduced-pressure dressing for applying reduced pressure treatment to a tissue site includes an absorbent pouch and a pump pouch.
- the absorbent pouch has an absorbent for absorbing liquid from the tissue site
- the pump pouch has a pump for applying reduced pressure to the tissue site through the absorbent pouch.
- the pump pouch is removably coupled to the absorbent pouch.
- a reduced-pressure dressing for applying reduced pressure treatment to a tissue site includes a manifold layer and an absorbent layer.
- the manifold layer is adapted to be positioned at the tissue site and the absorbent layer is in fluid communication with the manifold layer.
- the reduced-pressure dressing includes a cover positioned over the absorbent layer to create a sealed space beneath the cover, and the cover has an aperture to allow fluid communication with the sealed space.
- the reduced-pressure dressing also includes an envelope comprising an upper sheet coupled to a lower sheet, and a pump positioned between upper and lower sheets.
- the reduced-pressure dressing includes a removable coupling between the envelope and the cover.
- FIG. 1 is a side, cross-section view of an illustrative embodiment of a system for treating a tissue site with reduced pressure, including a reduced-pressure dressing coupled to the tissue site;
- FIG. 2 is a side, cross-section view of the illustrative reduced-pressure dressing of FIG. 1 , including a removable coupling between an electronics pouch and an absorbent pouch of the reduced-pressure dressing;
- FIG. 2A is a detail view of a portion of the reduced-pressure dressing that includes a perforation
- FIG. 3 is a top view of the reduced-pressure dressing
- FIG. 4 is a side, cross-section view of the reduced-pressure dressing that shows the electronics pouch being separated from the absorbent pouch;
- FIG. 5 is a side, cross-section view showing another illustrative reduced-pressure dressing having a removable coupling between the electronics pouch and absorbent pouch of the reduced-pressure dressing;
- FIG. 5A is a detail, cross-section view of the reduced-pressure dressing of FIG. 5 ;
- FIG. 6A is a side, cross-section view of an illustrative embodiment of a reduced-pressure dressing having an intermediate cover member and a sealing member that comprises a first sealing member connector and a second sealing member connector;
- FIG. 6B is a detail, cross-section view of the reduced-pressure dressing of FIG. 6 in an exploded state
- FIG. 7 is a side, cross-section view of an illustrative reduced-pressure dressing having an intermediate cover member that comprises a first cover connector and a second cover connector;
- FIG. 8A is a top view of an illustrative embodiment of a reduced-pressure dressing having an arcuate shape
- FIG. 8B is a perspective view showing the electronics pouch of the reduced-pressure dressing of FIG. 8A being separated from the absorbent pouch along a perforation;
- FIG. 9 is an exploded, perspective view of an illustrative embodiment of a reduced pressure dressing having first envelope that is removably coupled to a second envelope.
- Wound dressings composed of traditional dressing materials typically do not contain electronic components. Yet recent and more advanced wound dressings include electronic components to deliver therapy to wounds and to monitor conditions at wound sites. This may pose a difficultly when the dressing has been used and the time comes to dispose of the dressing.
- Used wound dressings that include biological or clinical waste are frequently required by law to be disposed by approved methods. For example, regulations may require the incineration of clinical waste to limit the risk of spreading disease. Similarly, the disposal of electronic components is also regulated by law in many jurisdictions. Such regulations may require that used electronic components be disassembled and recycled, or sent to a specific waste handling center that is equipped to dispose of electronic components with minimal environmental impact. The approved methods for disposing of clinical waste and electronic waste, however, are normally not compatible with one another.
- the electronic components may be separated from the clinical waste prior to disposal. After separation, the clinical waste portion and electronic waste portions of the spent wound dressing may be sent to different facilities for disposal. Depending on the configuration of the wound dressing, however, separating the electronics from the remainder of the wound dressing may be messy, impractical, and unsanitary.
- the illustrative embodiments include a wound dressing that functions as a single unit to treat a wound but allows for the separation of the electronic components from components that have absorbed clinical waste prior to disposal. Such a wound dressing allows the appropriate disposal of the clinical waste and recycling of electronic components.
- the illustrative embodiments also include wound dressing components that may be recombined to enable a wound dressing to stay in place while electronic components, such as batteries, are replaced to extend the life of the wound dressing.
- the illustrative embodiments provide a reduced-pressure wound dressing having a reliable seal between dressing components that can be broken apart without exposing a user or caregiver to unnecessary contact with fluids absorbed by the dressing.
- the reduced-pressure wound dressing allows for easy and appropriate disposal of the components depending on the type of waste (e.g., as clinical waste or electronic waste).
- the illustrative embodiments provide an integrated wound dressing and reduced-pressure source (i.e., a pump) that may be manufactured either as a single unit or as separate modules. Parts of a modular system may be manufactured in separate facilities and different sterilization processes may be employed to different components of the system.
- portions of the dressing that include electronic components may be sterilized using Ethylene Oxide, Super Critical Carbon Dioxide, or other sterilization methods that do not degrade the electronics.
- Other portions of the dressing may be sterilized using other methods, such as Gamma Irradiation or E-Beam sterilization, dependent on material compatibility.
- An illustrative reduced-pressure dressing alleviates the need for a remote reduced-pressure source or therapy unit that is connected via a tube or conduit, as used by more typical dressings that provide reduced pressure to a tissue site.
- the illustrative reduced-pressure dressing is a self-contained dressing or therapy unit that can be separated on disposal with minimal user intervention and effort.
- an absorbent, reduced-pressure dressing has an onboard reduced-pressure source, control system, and power source.
- a tissue site 102 e.g., a wound 104 or a cavity
- the tissue site 102 may be, for example, the wound 104 extending through epidermis 156 and into subcutaneous tissue 158 , or any other tissue site.
- Reduced pressure generally refers to a pressure less than the ambient pressure at a tissue site that is being subjected to treatment. In most cases, this reduced pressure will be less than the atmospheric pressure at which the patient is located.
- the reduced pressure may be less than a hydrostatic pressure at the tissue site 102 .
- values of pressure stated herein are gauge pressures.
- the reduced pressure delivered may be constant or varied (patterned or random) and may be delivered continuously or intermittently. Consistent with the use herein, unless otherwise indicated, an increase in reduced pressure or vacuum pressure typically refers to a relative reduction in absolute pressure.
- the system 100 includes a reduced-pressure dressing 106 for disposing proximate to the tissue site 102 .
- the reduced-pressure dressing 106 includes absorbent materials and has the ability to deliver reduced pressure to the tissue site 102 .
- the reduced-pressure dressing 106 includes an absorbent pouch 114 fluidly sealed and mechanically connected, or coupled, to an electronics pouch 116 by a removable coupling 118 or a sealing member 154 that pneumatically connects the pouches.
- the word “or” is not mutually exclusive.
- the electronics pouch 116 and absorbent pouch 114 are joined together such that there is a secure bond between the pouches.
- the secure bond may be a high-frequency weld around the periphery of the electronics pouch 116 .
- FIGS. 2-9 show similar systems, and variation is shown between figures in order to show some of the potential variations in the illustrative system 100 .
- the system 100 may be used with various different types of tissue sites 102 .
- the tissue site 102 may be the bodily tissue of any human, animal, or other organism, including bone tissue, adipose tissue, muscle tissue, dermal tissue, vascular tissue, connective tissue, cartilage, tendons, ligaments, body cavity or any other tissue.
- Treatment of the tissue site 102 may include removal of fluids, e.g., exudate or ascites.
- the electronics pouch 116 of the reduced-pressure dressing 106 is formed by coupling a first electronics cover 120 to a second electronics cover 122 , wherein the second electronics cover 122 is on the patient-facing side of the electronics pouch 116 .
- one or more sub parts e.g., sheets of elastomeric film, form the first electronics cover 120 and the second electronics cover 122 .
- the electronics pouch 116 may also be formed by other techniques such as casting or molding the electronics pouch 116 from a polymer.
- the electronics pouch 116 , or pump pouch, of FIG. 1 includes a pump 108 .
- the pump 108 is mounted to a substrate 132 that is formed from a printed circuit board material such as polyimide, phenolic or another suitable material.
- the electronics pouch may also include a processor, a power source, and a communication system (not shown) that control the pump 108 , power the pump 108 , and transmit and receive data.
- the pump 108 delivers reduced-pressure to the absorbent pouch 114 through an aperture 178 in the substrate 132 that is coupled to the second electronics cover 122 .
- the first electronics cover 120 of the electronics pouch 116 includes a vent 176 to fluidly couple an exhaust from the pump 108 to an exterior of the reduced-pressure dressing 106 .
- An odor filter 177 may be installed within the vent 176 to prevent the reduced-pressure dressing 106 from emitting odor from the wound 104 .
- the pump 108 may be a micro-pump device and may take numerous forms, such as a piezoelectric pump, peristaltic pump, or other miniaturized pump.
- the pump 108 is an acoustic resonance pump that applies the principle of acoustic resonance to generate pressure oscillations within a cavity and motivate fluid through the pump 108 .
- the pump 108 may be the type of micro-pump shown in United States Patent Publication 2009/0240185 (application Ser. No. 12/398,904; filed 5 Mar. 2009), entitled, “Dressing and Method for Applying Reduced Pressure To and Collecting And Storing Fluid from a Tissue Site,” which is incorporated herein for all purposes.
- the pump 108 is small and light enough to allow the reduced-pressure dressing 106 to be maintained on the tissue site 102 without causing discomfort to the patient.
- the size and weight of the micro-pump may be such that the reduced-pressure dressing 106 does not pull or otherwise adversely affect the tissue site 102 .
- the micro-pump may be a disc pump having a piezoelectric actuator similar to that previously described.
- the pump 108 has sufficient flow, reduced pressure, and operation life characteristics to enable continuous application of reduced pressure treatment.
- the flow may range between about 5-1000 ml/min and the reduced pressure may range between about ⁇ 50 and ⁇ 200 mm Hg ( ⁇ 6.6 to ⁇ 26.6 kPa). It should be understood that alternative ranges may be utilized depending on the configuration of the reduced-pressure dressing 106 , size of wound, or type of wound. In one illustrative embodiment, multiple pumps may be positioned in a single dressing to deliver increased flow rates or vacuum levels as required.
- the pump 108 In use, the pump 108 generates reduced pressure that is delivered to the tissue site 102 via the absorbent pouch 114 . To deliver reduced-pressure to the tissue site 102 , the pump 108 applies reduced-pressure through the aperture 178 in the substrate 132 or an aperture in the pump base if no substrate 132 is present.
- a sealing member 154 having a sealing member aperture 140 fluidly couples the electronics pouch 116 to the absorbent pouch 114 .
- the sealing member 154 provides a fluid seal by coupling to, for example, the substrate 132 of the electronics pouch 116 and the absorbent pouch 114 .
- the reduced-pressure dressing 106 omits the sealing member 154 and the electronics pouch 116 and absorbent pouch 114 are fluidly coupled by a direct coupling.
- the absorbent pouch 114 may receive and retain fluids from the tissue site 102 .
- the sealing member 154 is a sealing ring that provides a pneumatic seal between the pump 108 and the absorbent pouch 114 .
- One side of the sealing ring may be bonded to the substrate 132 to which the pump 108 is mounted and the other side of the sealing ring may be bonded to the absorbent pouch 114 .
- the absorbent pouch 114 applies reduced pressure from the pump 108 to the tissue site 102 .
- the absorbent pouch 114 includes a manifold layer 124 formed from a manifold material and is applied adjacent to the tissue site 102 to distribute reduced pressure.
- a manifold is a substance or structure that assists in applying reduced pressure to, delivering fluids to, or removing fluids from a tissue site 102 .
- the manifold layer 124 typically includes a plurality of flow channels or pathways that distribute fluids provided to and removed from the tissue site 102 around the manifold layer 124 . In one illustrative embodiment, the flow channels or pathways are interconnected to improve distribution of fluids provided to or removed from the tissue site 102 .
- the manifold layer 124 may be a biocompatible material that is capable of being placed in contact with the tissue site 102 and distributing reduced pressure to the tissue site 102 .
- materials used to form the manifold layer 124 may include without limitation the following: materials that have structural elements arranged to form flow channels, e.g., cellular foam, open-cell foam, porous tissue collections, liquids, gels, and foams that include, or cure to include, flow channels; foam; gauze; felted mat; or any other material suited to a particular biological application.
- the manifold layer 124 is a porous foam and includes a plurality of interconnected cells or pores that act as flow channels.
- the porous foam may be a polyurethane, open-cell, reticulated foam such as GranuFoam® material available from Kinetic Concepts, Incorporated of San Antonio, Tex.
- the manifold layer 124 may also be used to distribute fluids such as medications, antibacterials, growth factors, and various solutions to the tissue site 102 .
- Other layers may be included in or on manifold layer 124 , such as absorptive materials, wicking materials, hydrophobic materials, and hydrophilic materials.
- the manifold layer 124 distributes reduced pressure generated by the pump 108 and may draw exudate from the wound 104 .
- the manifold layer 124 is coupled to an absorbent layer 110 that functions to receive and retain fluids such as exudate from the tissue site 102 .
- the absorbent layer 110 may be made from any material capable of absorbing liquid.
- the absorbent layer 110 may be made from super absorbent fibers.
- the super absorbent fibers may retain or bond to the liquid in conjunction with a physical or chemical change to the fibers.
- the super absorbent fiber may include the Super Absorbent Fiber (SAF) material from Technical Absorbents, Ltd. of Grimsby, United Kingdom.
- SAF Super Absorbent Fiber
- the absorbent layer 110 may be a sheet or mat of fibrous material in which the fibers absorb liquid from the tissue site 102 .
- the structure of the absorbent layer 110 that contains the fibers may be either woven or non-woven.
- the fibers in the absorbent layer 110 may gel upon contact with the liquid, thereby trapping the liquid. Spaces or voids between the fibers may allow reduced pressure that is applied to the absorbent layer 110 to be transferred within and through the absorbent layer 110 .
- a liquid-air separator 112 e.g., a hydrophobic filter, may be placed between absorbent layer 110 and a first cover of the absorbent pouch 114 .
- the first cover 126 of the absorbent pouch 114 is coupled about the perimeter of the sealing member 154 to form a fluid seal.
- an intermediate manifold may be applied between the reduced-pressure dressing 106 and a portion of the tissue site 102 .
- the intermediate manifold may be constructed from bioresorbable materials that may remain in a patient's body following use of the reduced-pressure dressing 106 .
- Suitable bioresorbable materials may include, without limitation, a polymeric blend of polylactic acid (PLA) and polyglycolic acid (PGA).
- the polymeric blend may also include without limitation polycarbonates, polyfumarates, and capralactones.
- the intermediate manifold may further serve as a scaffold for new cell-growth, or a scaffold material may be used in conjunction with the intermediate manifold to promote cell-growth.
- a scaffold is a substance or structure used to enhance or promote the growth of cells or formation of tissue, such as a three-dimensional porous structure that provides a template for cell growth.
- Illustrative examples of scaffold materials include calcium phosphate, collagen, PLA/PGA, coral hydroxy apatites, carbonates, or processed allograft materials.
- the reduced-pressure dressing 106 also includes an interface layer, or comfort layer, for placing between the tissue site 102 and the manifold layer 124 .
- the absorbent pouch 114 maintains a fluid coupling with the tissue site 102 to apply reduced-pressure.
- the perimeter of the absorbent pouch 114 may be coupled to the tissue site 102 to form a sealed space.
- This coupling creates a fluid seal around the tissue site 102 that may be achieved by coupling the first cover 126 of the absorbent pouch 114 to the tissue site 102 using an attachment device.
- the first cover 126 is coupled to the manifold layer 124 or a comfort layer so that the absorbent layer 110 will maintain structural integrity when removed from the tissue site 102 .
- the first cover 126 is coupled to a second cover 128 in the manner described above with regard to the first electronics cover 120 and second electronics cover 122 of the electronics pouch 116 .
- the second cover 128 is coupled to the tissue site 102 to create the fluid seal when the reduced-pressure dressing 106 is applied to the tissue site 102 .
- the coupling between the first cover 126 and second cover 128 prevents the layers of the absorbent pouch 114 from separating so that the absorbent pouch 114 may be discarded as a unit.
- the first cover 126 and second cover 128 of the absorbent pouch 114 , and the first electronics cover 120 and second electronics cover 122 of the electronics pouch 116 may be formed from an impermeable or semi-permeable, elastomeric material.
- Elastomeric materials have the properties of an elastomer or, more generally, a polymeric material that has rubber-like properties. More specifically, most elastomers have ultimate elongations greater than 100% and a significant amount of resilience. The resilience of a material refers to the material's ability to recover from an elastic deformation.
- elastomers include, but are not limited to, natural rubbers, polyisoprene, styrene butadiene rubber, chloroprene rubber, polybutadiene, nitrile rubber, butyl rubber, ethylene propylene rubber, ethylene propylene diene monomer, chlorosulfonated polyethylene, polysulfide rubber, polyurethane (PU), EVA film, co-polyester, and silicones.
- Additional, specific examples of dressing sealing member materials include a silicone drape, 3M Tegaderm® drape, polyurethane (PU) drape such as one available from Avery Dennison Corporation of Pasadena, Calif.
- the reduced-pressure dressing forms a sealed space over the tissue site 102 , which may or may not contain the pump 108 .
- the elastomeric material may be a tin, flexible elastomeric film.
- An attachment device 162 may be used to couple the first cover 126 or second cover 128 to the patient's epidermis or another intermediate layer, such as a gasket or additional sealing device.
- the attachment device 162 may take numerous forms.
- the attachment device 162 may be a medically acceptable, pressure-sensitive adhesive that extends about a periphery or all of the first cover 126 (or second cover 128 ) or covers at least a portion of a patient-facing side of the reduced-pressure dressing 106 over the epidermis 156 .
- the reduced-pressure dressing 106 includes the removable coupling 118 between the electronics pouch 116 and the absorbent pouch 114 .
- the removable coupling 118 allows a caregiver to separate the electronics pouch 116 from the absorbent pouch 114 by exerting a force on a portion of the electronics pouch 116 , such as tab 130 .
- An example of such a removable coupling is described in more detail with regard to FIGS. 2-4 .
- the reduced-pressure dressing 206 includes a removable coupling 218 that facilitates the separation of the electronics pouch 216 from the absorbent pouch 214 after use.
- the removable coupling 218 includes a first bond 236 and a second bond 238 offset from the first bond 236 .
- the first bond 236 and second bond 238 may be any suitable type of joining technology, bond or coupling, including a high frequency weld, an ultrasonic weld, a heat weld, an adhesive bond, and a molded part line.
- the first bond 236 couples a second electronics cover 222 to a first cover 226 of an absorbent pouch 214 .
- the second bond 238 is offset from the first bond 236 and further from the perimeter 278 of the reduced-pressure dressing 206 than the first bond 236 .
- the first bond 236 should be strong enough so that unintended separation of the electronics pouch 216 from the absorbent pouch 214 does not occur.
- the first bond 236 may be a weld or other joint that provides a pneumatic seal, but a pneumatic seal between the pouches may instead be provided by another component or weld that is within the boundary of the first bond 236 , such as a sealing member 254 .
- a perforation 234 extends through the first electronics cover 220 and second electronics cover 222 between the first bond 236 and second bond 238 , i.e., inside of the first bond 236 but outside of the second bond 238 .
- the perforation 234 provides a separation line where the first electronics cover 220 and second electronics cover 222 can be torn to separate the electronics pouch 216 from the absorbent pouch 214 .
- the first electronics cover 220 may include a tab 230 bonded to the first electronics cover 220 using any of the bond types described above, or formed integrally to the first electronics cover 220 .
- the first electronics cover 220 may include a hole that allows a separation force to be exerted on the electronics pouch 216 .
- pulling the tab 230 causes a tear to develop and propagate along the weakened path of the perforation 234 until the electronics pouch 216 separates from the absorbent pouch 214 .
- the first bond 236 couples the second electronics cover 222 to both the first electronics cover 220 and first cover 226 .
- the first bond 236 couples the first electronics cover 220 to the second electronics cover 222 .
- the second electronics cover 222 couples to the first cover 226 at any suitable location that is outside of the perforation 234 to preserve the coupling of the electronics pouch 216 to the absorbent pouch 214 until the electronics pouch 216 is torn along the perforation 234 .
- the dimensions of the perforation 234 are dependent on the material used to manufacture the electronics pouch 216 or absorbent pouch 214 as well as the location of the perforation 234 .
- the perforation 234 should weaken the material so that the strength of the perforated area is significantly less than the tear strength of the pouch material.
- the perforation 234 may have the dimensions of 0.1 mm land and between 0.1 mm and 0.5 mm space.
- FIG. 3 illustrates a possible arrangement of the first bond 236 , perforation 234 , and second bond 238 and FIG. 4 shows how the electronics pouch 216 separates from the absorbent pouch 214 after being torn along the perforation 234 .
- the portion of the reduced-pressure dressing 206 that retains the absorbent pouch 214 has a first perforation line 234 a and the electronics pouch 216 has a second perforation line 234 b indicating the points of separation.
- the sealing member 254 is shown as being coupled to the patient-facing side of the electronics pouch 216 and releasably coupled to the absorbent pouch 214 . In another embodiment, however, the sealing member 254 is coupled to the absorbent pouch 214 and releasably coupled to the electronics pouch 216 .
- the sealing member 254 is a sealing ring, and an adhesive is used to couple the sealing ring to the substrate 232 of the pump 208 or to the first cover 226 of the absorbent pouch 214 .
- the properties of the adhesive applied to the surfaces of the sealing ring may be altered so that when the pouches are separated, the sealing ring remains adhered to either the substrate 232 or the first cover 226 . If the sealing ring is attached by welding, the seal ring itself can have a weakened area to facilitate tearing to separate the sealing ring from the electronics pouch 216 or absorbent pouch 214 when the electronics pouch 216 is removed. The sealing ring may then be disposed appropriately.
- Adhesives that may be used to adhere the sealing ring to the substrate 232 of the first cover 226 Acrylic Pressure Sensitive Adhesives (PSA) based such as 3M 927, or a UV liquid adhesive such as Dymax 1201-M-SC.
- PSA Pressure Sensitive Adhesives
- the sealing member 254 may be a single flexible material that has adhesive coating on each side to couple to the electronics pouch 216 and absorbent pouch 214 .
- the sealing member 254 also provides a fluid seal between the electronics pouch 216 and absorbent pouch 214 .
- the flexible material may be a closed cell foam, such as a foam manufactured from neoprene or ethylene-vinyl acetate (EVA). Additionally, the flexible material may provide a level of padding between the electronics pouch 216 and absorbent pouch 214 , thereby adding flexibility to the reduced-pressure dressing 206 .
- the sealing member material may be a solid elastomeric material, such as a thermoplastic elastomer (TPE), or a rigid material. Where an adhesive is used to hold the sealing member 254 in place, the adhesive properties can be altered between the two sides of the sealing member 254 so that on separation, the sealing member 254 remains coupled to either the electronics pouch 216 or the absorbent pouch 214 .
- the electronics pouch 216 couples directly to the absorbent pouch 214 .
- a portion of the electronics pouch 216 or the absorbent pouch 214 may include a breakaway feature, such as a weakened area in the pouch material or a breakaway feature in the substrate 232 to facilitate separation of the pouches.
- FIGS. 2-4 show that a caregiver may separate the electronics pouch 216 from the absorbent pouch 214 by grasping the tab 230 and exerting a force to tear the first electronics cover 220 and second electronics cover 222 around the perimeter of the electronics pouch 216 .
- the electronics pouch 216 may be grasped and pulled to apply pressure to the sealing member 254 , which may be a sealing ring. Once the sealing member 254 is separated from the electronics pouch 216 , the electronics pouch 216 is completely free from the absorbent pouch 214 and the pouches may be discarded separately.
- FIG. 5 shows another illustrative embodiment of a reduced-pressure dressing 306 that is similar in many respects to the dressings of FIGS. 1-4 but omits a second electronics cover.
- an upper layer of the absorbent pouch 314 such as the a liquid-air separator 312 , is coupled to the first cover 326 by a first bond 336 .
- the first cover 326 Inside of the first bond, the first cover 326 includes a perforation 334 . Inside of the perforation 334 , the first cover 326 is coupled to the first electronics cover 320 by a second bond 338 .
- the first cover 326 is also coupled to the substrate 332 that forms a portion of patient-facing side of the electronics pouch 316 .
- the reduced-pressure dressing 306 may be torn along the perforation 334 to separate the electronics pouch 316 from the absorbent pouch 314 .
- the tab 330 may merely be an extension of the first electronics cover 320 .
- FIGS. 6A and 6B show another illustrative embodiment of a reduced-pressure dressing 406 having an electronics pouch 416 attached to an absorbent pouch 414 by a removable coupling 418 .
- the first cover 426 of the absorbent pouch 414 is coupled to a proximate side of the sealing member 454 .
- the opposing side of the sealing member 454 is coupled to the second electronics cover 422 or the substrate 432 of the electronics pouch 416 .
- the first cover 426 and first electronics cover 420 (or second electronics cover 422 ) are coupled to one another by the removable coupling 418 , which is an intermediate cover member 450 .
- the intermediate cover member 450 may include a perforation or be formed of a material that is easier to tear than the material that forms the pouches to facilitate separation of the electronics pouch 416 from the absorbent pouch 414 .
- the intermediate cover member 450 provides a fluid seal between the electronics pouch 416 and the absorbent pouch 414 , thereby alleviating the need for a sealing member 454 .
- the intermediate cover member 450 may add flexibility between the absorbent pouch 414 and electronics pouch 416 in such an embodiment.
- the intermediate cover member 450 is bonded to the substrate 432 to which the pump 408 is mounted and bonded or welded to the first cover 426 of the absorbent pouch 414 .
- the material that forms the intermediate cover member 450 is selected such that, when the electronics pouch 416 is separated from the absorbent pouch 414 , the intermediate cover member 450 will break before the integrity of either pouch is compromised. In another embodiment, the separation occurs at either the bond between the intermediate cover member 450 and the absorbent pouch 414 or the bond between the intermediate cover member 450 and the electronics pouch 416 .
- the sealing member 454 is formed from a first sealing connector 442 coupled to the substrate 432 of the electronics pouch 416 and a second sealing connector 444 coupled to the absorbent pouch 414 .
- the first sealing connector 442 is releasably coupled to the second sealing connector 444 .
- FIG. 6B shows, the releasable coupling between the first sealing connector 442 and second sealing connector 444 results in the first sealing connector 442 remaining coupled to the electronics pouch 416 and the second sealing connector 444 remaining coupled to the absorbent pouch 414 when the pouches are separated.
- the sealing member 454 or second sealing connector 444 includes additional elements, such as a liquid-air separator 446 and an odor filter 448 .
- the sealing member 454 may alleviate the need for such an element in the absorbent pouch, enabling a smaller part to perform the function of preventing liquids (e.g., exudate) from entering the electronics pouch 416 .
- the sealing member 454 may include the odor filter 448 , which may be a charcoal filter, thereby alleviating the need to install such an element in another portion of the reduced-pressure dressing 406 .
- the sealing member 454 may be formed from a polymer, such as a polyvinyl chloride (PVC) or acrylonitrile butadiene styrene (ABS) polymer.
- the sealing member 454 may instead be formed from polyurethane or another suitable material that is compatible with the pouch cover material and weldable using a high-frequency welding process. In one embodiment, the sealing member 454 couples to the second electronics cover 422 or directly to the substrate 432 using an adhesive.
- a breakable connection piece is securely bonded to both the electronics pouch 416 and absorbent pouch 414 to serve the function of both a sealing member 454 and intermediate cover member 450 .
- the pouches may be separated by breaking the breakable connection piece.
- a breakable connection piece may be manufactured from a plastic molding having a weakened breakaway area that causes the breakable connection piece to break in a predictable and controllable manner.
- the breakable connection piece may be made from an injection molded thermoplastic polyurethane (TPU), such as Pellethane® 2363-80AE having a durometer of 80 on the Shore A scale.
- the thickness of the weakened area may be in the range of 0.05 mm to 0.08 mm, thereby enabling a controlled tear, or break, to be induced without risking damage or undesirable disassembly of the electronics pouch 416 or absorbent pouch 414 .
- the breakable connection piece contains an odor filter and a liquid-air separator.
- the breakable connection piece may also be manufactured from a porous polymer, e.g., a sintered polymer, that has been treated to provide liquid and odor blocking functions.
- the breakable connection piece may include hydrophobic materials for liquid separation and activated carbon particles for odor control.
- the breakable connection piece In the case of a sintered polymer material, the breakable connection piece would not include an aperture, but would be a gas permeable structure having a sealed outer surface such that gas would be pulled through the breakable connection piece to transmit reduced-pressure.
- the outer surface of the breakable connection piece formed from the sintered polymer should be coated with a gas impermeable coating to provide a seal.
- the breakable connection piece may include an electrical connection.
- the electrical connection may electrically couple one or more sensors in the absorbent layer 410 to the processor of the electronics pouch 416 .
- the reduced-pressure dressing 406 may include sensors to measure the fluid capacity of the dressing, the mechanical or pneumatic pressure at the tissue site, the pH of the wound, and other characteristics of the tissue site.
- the electrical coupling may also be used to provide power to a therapeutic system mounted within the absorbent layer 410 that requires power or monitoring, such as a wound camera or electrical stimulation system.
- a RF device such as a RFID antenna
- the breakable connection piece may provide additional space to mount related electrical components.
- the breakable connection piece may provide multiple channels or lumens from the electronics pouch 416 to the absorbent pouch 414 , which may enable the monitoring of pressure in specific areas of the reduced-pressure dressing.
- a TRAC system may be used to determine absorbent saturation or other characteristics of a tissue site where substances are being delivered to a wound.
- the reduced-pressure dressing may be configured to deliver anti-microbial agents, analgesics, and cleansing solutions.
- the intermediate cover member 450 is an adhesive layer that provides a fluid seal between the electronics pouch 416 and absorbent pouch 414 .
- the adhesive layer may be configured to allow the electronics pouch 416 to be separated from the absorbent pouch 414 by peeling the pouches apart.
- the intermediate cover member 450 may be a film joined to the electronics pouch 416 and absorbent pouch 414 by a suitable method, such as bonding or welding.
- the film may be manufactured so that the film is weaker than the adjacent materials, thereby allowing the film to break instead of the adjacent electronics pouch 416 and absorbent pouch 414 as the pouches are pulled apart.
- a separation mechanism such as a string or strip of material is included beneath the film, such that pulling the string outward will cause the string or strip to unwind and tear the film to facilitate separation of the pouches.
- FIG. 7 shows another illustrative embodiment of a reduced-pressure dressing 506 that includes an electronics pouch 516 and an absorbent pouch 514 .
- reduced-pressure is transmitted from a pump 508 of the electronics pouch 516 to the absorbent pouch 514 via sealing member 554 .
- the electronics pouch 516 is coupled to the absorbent pouch 514 by an intermediate cover member 550 that is manufactured from multiple parts, such as a first cover connector 562 and a second cover connector 564 .
- the first cover connector 562 and second cover connector 564 are formed from different polymers so that adhesion between the first cover connector 562 and second cover connector 564 is strong enough to provide a fluid seal but weak enough to be easily broken.
- the second cover connector may be formed from polypropylene or high-impact polystyrene.
- the second cover connector 564 may be formed from polyurethane or another suitable material that is compatible with the pouch cover material and weldable using a HF welding process.
- a fluid seal between the first cover connector 562 and second cover connector 564 is obtained by an interference fit between the connectors.
- the first cover connector 562 and second cover connector 546 may be mating parts having a snap fit or twist-lock feature with sealing surfaces to maintain a fluid seal.
- the first cover connector 562 is coupled to the first cover 526 of the absorbent pouch 514 by an adhesive or weld, or by forming the first cover connector integrally to the first cover 526 .
- the second cover connector 564 couples to the electronics pouch 516 in a similar manner.
- one of the parts e.g., the first cover connector 562 may be manufactured by injection molding.
- the second cover connector 564 is then combined with the first cover connector 562 using an overmolding process.
- the overmolding process allows different materials to be used that are optimized for the joining process used at each interface.
- the first cover connector 562 may be suitable for welding to a polymer surface of the absorbent pouch 514 while the second cover connector 564 is better suited for adhesive bonding to a surface of the electronics pouch 516 (e.g., to a polyimide or phenolic PCB substrate).
- the first cover connector 562 is installed in a mold, which is used to form the second cover connector 564 by overmolding the second cover connector 564 to the first cover connector 562 .
- the overmolding process results in a part line 566 at the junction of the first cover connector 562 and second cover connector 564 .
- the part line 566 may be formed such that when a separation force is applied to the pouches, the electronics pouch 516 separates from the absorbent pouch 514 along the part line 566 .
- the part line 566 may be a flat surface or may include a mechanical interlock feature that enhances sealing.
- the polymeric bond between the first cover connector 562 and second cover connector 564 is less important for the purposes of creating a fluid seal, and a weaker bond may be acceptable.
- the first cover connector 562 and the second cover connector 564 may be formed from dissimilar materials that will not form a strong bond to one another.
- a coating may be applied to the first cover connector 562 along the part line 566 to prevent the second cover connector 564 from permanently bonding to the first cover connector 562 . In this way, the first cover connector 562 may be removably coupled to the second cover connector 564 to maintain a fluid seal until the electronics pouch 516 is separated from the absorbent pouch 514 .
- a fluid seal between the first cover connector 562 and second cover connector 564 may be more easily obtained by using an overmolding process than another manufacturing process because manufacturing tolerances and dimensional variations at the interface are negated by the overmolding process.
- the overmolding process also facilitates the joining of dissimilar materials. For example, in an embodiment in which there is a difference in hardness between the first cover connector 562 and the second cover connector 564 , the connector formed from the softer polymer is formed using the overmolding process, while the opposing connector is formed using the injection molding process.
- first cover connector 562 and second cover connector 564 include mechanical interlocking features, the softer connector may be more easily deformed to separate from the harder connector.
- both the first cover connector 562 and second cover connector 564 are injection molded and assembled together to provide a sealed coupling.
- a more rigid part is manufactured from a material other than a thermoplastic (e.g., thermoset polymer), other manufacturing techniques may be employed.
- the absorbent pouch 514 remains in place at a tissue site while the electronics pouch 516 is removed to, for example, renew the power source of the pump 508 .
- the power source of the pump 508 may be replaced within the electronics pouch 516 and the electronics pouch 516 may be reapplied or replaced with a new electronics pouch 516 to extend the life of the reduced-pressure dressing 506 .
- FIGS. 8A and 8B show an embodiment of a reduced-pressured dressing 606 having an arcuate shape.
- the reduced-pressure dressing 606 is generally analogous to the dressing of FIG. 1 .
- the reduced-pressure dressing 606 includes an absorbent pouch 614 having a first cover 626 .
- the absorbent pouch 614 receives reduced-pressure from a pump that is housed within an electronics pouch 616 .
- the electronics pouch 616 is removably coupled to absorbent pouch at a first bond 636 and a second bond 638 .
- the first cover 620 of the electronics pouch 616 includes a tab 630 that can be pulled to initiate a tear along the perforation 634 to separate the pouches.
- FIG. 9 shows an exploded view of a reduced-pressure dressing 706 that contains additional layers but is similar in many respects to the dressings discussed above.
- the reduced-pressure dressing 706 is shown in a rectangular form but may be formed to have any suitable shape for application to a tissue site.
- the reduced-pressure dressing may be shaped to resemble the reduced-pressure dressing 606 of FIGS. 8A and 8B .
- the reduced-pressure dressing 706 includes an optional intermediate manifold 768 that may be placed adjacent the tissue site, as discussed above.
- the reduced-pressure dressing 706 includes a first cover 726 and a second cover 728 .
- the second cover 728 has a first side 780 and a second, patient-facing side 781 .
- the second, patient-facing side 781 may be coated with a releasable adhesive to facilitate application to a tissue site.
- the second cover 728 also includes a treatment aperture 782 for placing over a portion of the tissue site (e.g., a wound) that receives reduced pressure.
- the reduced-pressure dressing 706 also includes a manifold layer 724 , which is an internal distribution manifold having a first side 783 and a second, patient-facing side 784 .
- the manifold layer 724 distributes reduced-pressure to the tissue site.
- the second, patient-facing side 784 of the manifold layer 724 is coupled to the first side 780 of the second cover 728 .
- An absorbent layer 710 which functions to receive and retain fluids from a tissue site, is coupled to the manifold layer 724 .
- a diverter layer 770 is coupled to the absorbent layer 710 .
- the diverter layer 770 is disposed adjacent to the absorbent layer 710 and the manifold layer 724 .
- the diverter layer 770 is formed from a liquid impermeable material but contains a plurality of apertures 785 .
- the plurality of apertures 785 allow reduced pressure to be transmitted through the diverter layer 770 at desired locations.
- the diverter layer 770 helps control the pattern of reduced pressure as applied to the absorbent layer 710 .
- the reduced pressure is distributed to the diverter layer 770 by a second manifold layer 772 that is coupled to the diverter layer 770 .
- the apertures 785 may be arranged in a pattern for applying the reduced pressure to portions of the absorbent layer 710 to enhance the capability of the absorbent layer 710 to continue transferring reduced pressure to the tissue site as the absorbent layer 710 absorbs more fluid from the tissue site.
- the diverter layer 770 acts in conjunction with the second manifold layer 772 to ensure that the absorption capabilities and absorption efficiency of the absorbent layer 710 are increased relative to an absorbent layer 710 that is not used in conjunction with a diverter layer 770 . By providing better distribution of liquid throughout the absorbent layer 710 , the diverter layer 770 also increases the effective capacity and treatment time of the reduced-pressure dressing 706 .
- the diverter layer 770 may be made from any material that enhances the reduced pressure transmission and storage capabilities of an adjacent absorbent layer.
- the diverter layer 770 may be made from a material that is substantially impermeable to liquid and gas and that diverts the reduced pressure to pass through apertures 785 .
- the material from which the diverter layer 770 is made may have a predetermined moisture vapor transfer rate that is consistent with gas permeability.
- the diverter layer 770 may still include a pattern of apertures for transmitting a greater volume of liquid or gas than that permitted by a gas-permeable material not having apertures. It should be noted, however, that permeability of the diverter layer 770 to gas but not liquid may result in increased transmission of reduced pressure through the dressing while still directing liquid flow around or near the perimeter of the diverter layer 770 .
- the reduced-pressure dressing 706 includes a liquid-air separator 712 coupled to the second manifold layer 772 and the first cover 726 , which is coupled about the perimeter to the second cover 728 .
- the first cover 726 includes an aperture 788 to receive reduced pressure.
- the first cover 726 and second cover 728 form a first envelope 786 enclosing the manifold layer 724 , absorbent layer 710 , diverter layer 770 , second manifold layer 772 , and liquid-air separator 712 .
- the reduced-pressure dressing 706 includes a pump 708 .
- the pump is mounted to a substrate 732 and coupled to a processor 760 and a power source 774 . Additional electronic components may be coupled to the pump 708 , processor 760 , or power source 774 as desired.
- the substrate 732 is enclosed between a first electronics cover 720 , which is coupled to a second electronics cover 722 to form a second envelope 787 .
- the first electronics cover 722 also includes a vent 776 to fluidly couple an exhaust of the pump 708 to the external environment and an odor filter may be installed between the exhaust of the pump 708 and the vent 776 to prevent odor from a wound from escaping the reduced-pressure dressing 706 .
- the substrate 732 and second electronics cover 722 also include apertures to facilitate the transmission of reduced pressure to the first envelope 786 .
- the second envelope 787 is removably coupled to the first envelope 786 using a removable coupling that provides a fluid seal.
- a portion of the second electronics cover 722 may be coupled to a portion of the second cover 728 .
- a sealing member 754 provides a sealed fluid path between the second envelope 787 and the first envelope 786 .
- the sealing member 754 includes an aperture for transmitting reduced-pressure generated by the pump 708 to the layers of the first envelope 786 for application to the tissue site.
Abstract
Description
- This application is a divisional of U.S. patent application Ser. No. 14/386,444, filed Sep. 19, 2014, which is a National Stage Entry of PCT/US2013/034472, filed Mar. 28, 2013, which claims benefit under 35 USC 119(e), of the filing of U.S. Provisional Patent Application Ser. No. 61/616,901, filed Mar. 28, 2012 and is herein incorporated by reference in its entirety.
- The present disclosure relates generally to medical treatment systems and, more particularly, but not by way of limitation, to reduced-pressure wound dressings, systems, and methods that facilitate the separation of clinical waste and electronics waste for efficient disposal.
- Clinical studies and practice have shown that providing a reduced pressure in proximity to a tissue site augments and accelerates the growth of new tissue at the tissue site. The applications of this phenomenon are numerous, but application of reduced pressure has been particularly successful in treating wounds. This treatment (frequently referred to in the medical community as “negative pressure wound therapy,” “reduced pressure therapy,” or “vacuum therapy”) provides a number of benefits, which may include faster healing and increased formulation of granulation tissue. Typically, when applied to open wounds, reduced pressure is applied to tissue through a porous pad or other manifold device of a reduced-pressure wound dressing. The porous pad distributes reduced pressure to the tissue and channels fluids that are drawn from the tissue into the dressing. When the reduced pressure therapy is completed or the reduced-pressure wound dressing is spent, the reduced-pressure wound dressing is removed from the tissue site and discarded.
- According to an illustrative embodiment, a reduced-pressure dressing for applying reduced pressure treatment to a tissue site includes an absorbent pouch and an electronics pouch. The absorbent pouch includes a manifold, an absorbent layer, and a first cover. The manifold layer is adapted to deliver reduced pressure to the tissue site, the absorbent layer is in fluid communication with the manifold layer to absorb liquid from at least one of the manifold layer and the tissue site, and the first cover is positioned over the absorbent layer and the manifold layer to maintain the reduced pressure at the tissue site. The electronics pouch is removably coupled to the absorbent pouch, and includes a pump and a second cover. The pump is adapted to provide fluid communication to the tissue site through at least one of the absorbent layer and the manifold layer, and the second cover has a first electronics cover and a second electronics cover. The second electronics cover is coupled to the first electronics cover and the pump is positioned between the first electronics cover and the second electronics cover.
- Another illustrative embodiment includes a method for disposing of a reduced-pressure dressing. The reduced-pressure dressing includes an electronics pouch removably coupled to an absorbent pouch. The absorbent pouch includes a tissue manifold layer, an absorbent layer in fluid communication with the tissue manifold layer, and a first cover. The method comprises pulling the electronics pouch to separate electronics pouch from the absorbent pouch along a weakened coupling between the electronics pouch and the absorbent pouch.
- According to another illustrative embodiment, a reduced-pressure dressing for applying reduced pressure treatment to a tissue site includes an absorbent pouch and a pump pouch. The absorbent pouch has an absorbent for absorbing liquid from the tissue site, and the pump pouch has a pump for applying reduced pressure to the tissue site through the absorbent pouch. The pump pouch is removably coupled to the absorbent pouch.
- According to another illustrative embodiment, a reduced-pressure dressing for applying reduced pressure treatment to a tissue site includes a manifold layer and an absorbent layer. The manifold layer is adapted to be positioned at the tissue site and the absorbent layer is in fluid communication with the manifold layer. The reduced-pressure dressing includes a cover positioned over the absorbent layer to create a sealed space beneath the cover, and the cover has an aperture to allow fluid communication with the sealed space. The reduced-pressure dressing also includes an envelope comprising an upper sheet coupled to a lower sheet, and a pump positioned between upper and lower sheets. The reduced-pressure dressing includes a removable coupling between the envelope and the cover.
- Other features and advantages of the illustrative embodiments will become apparent with reference to the drawings and detailed description that follow.
-
FIG. 1 is a side, cross-section view of an illustrative embodiment of a system for treating a tissue site with reduced pressure, including a reduced-pressure dressing coupled to the tissue site; -
FIG. 2 is a side, cross-section view of the illustrative reduced-pressure dressing ofFIG. 1 , including a removable coupling between an electronics pouch and an absorbent pouch of the reduced-pressure dressing; -
FIG. 2A is a detail view of a portion of the reduced-pressure dressing that includes a perforation; -
FIG. 3 is a top view of the reduced-pressure dressing; -
FIG. 4 is a side, cross-section view of the reduced-pressure dressing that shows the electronics pouch being separated from the absorbent pouch; -
FIG. 5 is a side, cross-section view showing another illustrative reduced-pressure dressing having a removable coupling between the electronics pouch and absorbent pouch of the reduced-pressure dressing; -
FIG. 5A is a detail, cross-section view of the reduced-pressure dressing ofFIG. 5 ; -
FIG. 6A is a side, cross-section view of an illustrative embodiment of a reduced-pressure dressing having an intermediate cover member and a sealing member that comprises a first sealing member connector and a second sealing member connector; -
FIG. 6B is a detail, cross-section view of the reduced-pressure dressing ofFIG. 6 in an exploded state; -
FIG. 7 is a side, cross-section view of an illustrative reduced-pressure dressing having an intermediate cover member that comprises a first cover connector and a second cover connector; -
FIG. 8A is a top view of an illustrative embodiment of a reduced-pressure dressing having an arcuate shape; -
FIG. 8B is a perspective view showing the electronics pouch of the reduced-pressure dressing ofFIG. 8A being separated from the absorbent pouch along a perforation; and -
FIG. 9 is an exploded, perspective view of an illustrative embodiment of a reduced pressure dressing having first envelope that is removably coupled to a second envelope. - In the following detailed description of the illustrative, non-limiting embodiments, reference is made to the accompanying drawings that form a part hereof. These illustrative embodiments are described in sufficient detail to enable those skilled in the art to practice the invention. It is understood that other embodiments may be utilized and that logical structural, mechanical, electrical, and chemical changes may be made without departing from the spirit or scope of the invention. To avoid detail not necessary to enable those skilled in the art to practice the embodiments described herein, the description may omit certain information known to those skilled in the art. The following detailed description is not to be taken in a limiting sense, and the scope of the illustrative embodiments is defined only by the appended claims.
- Wound dressings composed of traditional dressing materials typically do not contain electronic components. Yet recent and more advanced wound dressings include electronic components to deliver therapy to wounds and to monitor conditions at wound sites. This may pose a difficultly when the dressing has been used and the time comes to dispose of the dressing. Used wound dressings that include biological or clinical waste are frequently required by law to be disposed by approved methods. For example, regulations may require the incineration of clinical waste to limit the risk of spreading disease. Similarly, the disposal of electronic components is also regulated by law in many jurisdictions. Such regulations may require that used electronic components be disassembled and recycled, or sent to a specific waste handling center that is equipped to dispose of electronic components with minimal environmental impact. The approved methods for disposing of clinical waste and electronic waste, however, are normally not compatible with one another. Thus, in the case of a used wound dressing that includes electronic components, the electronic components may be separated from the clinical waste prior to disposal. After separation, the clinical waste portion and electronic waste portions of the spent wound dressing may be sent to different facilities for disposal. Depending on the configuration of the wound dressing, however, separating the electronics from the remainder of the wound dressing may be messy, impractical, and unsanitary.
- The illustrative embodiments include a wound dressing that functions as a single unit to treat a wound but allows for the separation of the electronic components from components that have absorbed clinical waste prior to disposal. Such a wound dressing allows the appropriate disposal of the clinical waste and recycling of electronic components. The illustrative embodiments also include wound dressing components that may be recombined to enable a wound dressing to stay in place while electronic components, such as batteries, are replaced to extend the life of the wound dressing.
- The illustrative embodiments provide a reduced-pressure wound dressing having a reliable seal between dressing components that can be broken apart without exposing a user or caregiver to unnecessary contact with fluids absorbed by the dressing. The reduced-pressure wound dressing allows for easy and appropriate disposal of the components depending on the type of waste (e.g., as clinical waste or electronic waste). In addition, the illustrative embodiments provide an integrated wound dressing and reduced-pressure source (i.e., a pump) that may be manufactured either as a single unit or as separate modules. Parts of a modular system may be manufactured in separate facilities and different sterilization processes may be employed to different components of the system. For example, portions of the dressing that include electronic components may be sterilized using Ethylene Oxide, Super Critical Carbon Dioxide, or other sterilization methods that do not degrade the electronics. Other portions of the dressing may be sterilized using other methods, such as Gamma Irradiation or E-Beam sterilization, dependent on material compatibility. An illustrative reduced-pressure dressing alleviates the need for a remote reduced-pressure source or therapy unit that is connected via a tube or conduit, as used by more typical dressings that provide reduced pressure to a tissue site. The illustrative reduced-pressure dressing is a self-contained dressing or therapy unit that can be separated on disposal with minimal user intervention and effort.
- In one embodiment, an absorbent, reduced-pressure dressing has an onboard reduced-pressure source, control system, and power source. Referring now to the drawings and initially to
FIG. 1 , an illustrative embodiment of asystem 100 for treating atissue site 102, e.g., awound 104 or a cavity, with reduced pressure is presented. Thetissue site 102 may be, for example, thewound 104 extending throughepidermis 156 and intosubcutaneous tissue 158, or any other tissue site. Reduced pressure generally refers to a pressure less than the ambient pressure at a tissue site that is being subjected to treatment. In most cases, this reduced pressure will be less than the atmospheric pressure at which the patient is located. Alternatively, the reduced pressure may be less than a hydrostatic pressure at thetissue site 102. Unless otherwise indicated, values of pressure stated herein are gauge pressures. The reduced pressure delivered may be constant or varied (patterned or random) and may be delivered continuously or intermittently. Consistent with the use herein, unless otherwise indicated, an increase in reduced pressure or vacuum pressure typically refers to a relative reduction in absolute pressure. - The
system 100 includes a reduced-pressure dressing 106 for disposing proximate to thetissue site 102. The reduced-pressure dressing 106 includes absorbent materials and has the ability to deliver reduced pressure to thetissue site 102. The reduced-pressure dressing 106 includes anabsorbent pouch 114 fluidly sealed and mechanically connected, or coupled, to anelectronics pouch 116 by aremovable coupling 118 or a sealingmember 154 that pneumatically connects the pouches. As used herein, the word “or” is not mutually exclusive. Theelectronics pouch 116 andabsorbent pouch 114 are joined together such that there is a secure bond between the pouches. The secure bond may be a high-frequency weld around the periphery of theelectronics pouch 116.FIGS. 2-9 show similar systems, and variation is shown between figures in order to show some of the potential variations in theillustrative system 100. - The
system 100 may be used with various different types oftissue sites 102. Thetissue site 102 may be the bodily tissue of any human, animal, or other organism, including bone tissue, adipose tissue, muscle tissue, dermal tissue, vascular tissue, connective tissue, cartilage, tendons, ligaments, body cavity or any other tissue. Treatment of thetissue site 102 may include removal of fluids, e.g., exudate or ascites. - Referring again to
FIG. 1 , theelectronics pouch 116 of the reduced-pressure dressing 106 is formed by coupling afirst electronics cover 120 to asecond electronics cover 122, wherein thesecond electronics cover 122 is on the patient-facing side of theelectronics pouch 116. In one embodiment, one or more sub parts, e.g., sheets of elastomeric film, form thefirst electronics cover 120 and thesecond electronics cover 122. Theelectronics pouch 116 may also be formed by other techniques such as casting or molding theelectronics pouch 116 from a polymer. Theelectronics pouch 116, or pump pouch, ofFIG. 1 includes apump 108. Within theelectronics pouch 116, thepump 108 is mounted to asubstrate 132 that is formed from a printed circuit board material such as polyimide, phenolic or another suitable material. The electronics pouch may also include a processor, a power source, and a communication system (not shown) that control thepump 108, power thepump 108, and transmit and receive data. In use, thepump 108 delivers reduced-pressure to theabsorbent pouch 114 through anaperture 178 in thesubstrate 132 that is coupled to thesecond electronics cover 122. The first electronics cover 120 of theelectronics pouch 116 includes avent 176 to fluidly couple an exhaust from thepump 108 to an exterior of the reduced-pressure dressing 106. Anodor filter 177 may be installed within thevent 176 to prevent the reduced-pressure dressing 106 from emitting odor from thewound 104. - The
pump 108 may be a micro-pump device and may take numerous forms, such as a piezoelectric pump, peristaltic pump, or other miniaturized pump. In one embodiment, thepump 108 is an acoustic resonance pump that applies the principle of acoustic resonance to generate pressure oscillations within a cavity and motivate fluid through thepump 108. Thepump 108 may be the type of micro-pump shown in United States Patent Publication 2009/0240185 (application Ser. No. 12/398,904; filed 5 Mar. 2009), entitled, “Dressing and Method for Applying Reduced Pressure To and Collecting And Storing Fluid from a Tissue Site,” which is incorporated herein for all purposes. - The
pump 108 is small and light enough to allow the reduced-pressure dressing 106 to be maintained on thetissue site 102 without causing discomfort to the patient. The size and weight of the micro-pump may be such that the reduced-pressure dressing 106 does not pull or otherwise adversely affect thetissue site 102. In one illustrative embodiment, the micro-pump may be a disc pump having a piezoelectric actuator similar to that previously described. Reference is also made to the pumps shown in United States Patent Publication 2009/0087323 and United States Patent Publication 2009/0240185, which are hereby incorporated by reference for all purposes. It should be understood that alternative pump technologies may be utilized and that rotary, linear, or other configurations of pumps may be utilized. - The
pump 108 has sufficient flow, reduced pressure, and operation life characteristics to enable continuous application of reduced pressure treatment. The flow may range between about 5-1000 ml/min and the reduced pressure may range between about −50 and −200 mm Hg (−6.6 to −26.6 kPa). It should be understood that alternative ranges may be utilized depending on the configuration of the reduced-pressure dressing 106, size of wound, or type of wound. In one illustrative embodiment, multiple pumps may be positioned in a single dressing to deliver increased flow rates or vacuum levels as required. - In use, the
pump 108 generates reduced pressure that is delivered to thetissue site 102 via theabsorbent pouch 114. To deliver reduced-pressure to thetissue site 102, thepump 108 applies reduced-pressure through theaperture 178 in thesubstrate 132 or an aperture in the pump base if nosubstrate 132 is present. In the embodiment ofFIG. 1 , a sealingmember 154 having a sealingmember aperture 140 fluidly couples theelectronics pouch 116 to theabsorbent pouch 114. The sealingmember 154 provides a fluid seal by coupling to, for example, thesubstrate 132 of theelectronics pouch 116 and theabsorbent pouch 114. In other embodiments, the reduced-pressure dressing 106 omits the sealingmember 154 and theelectronics pouch 116 andabsorbent pouch 114 are fluidly coupled by a direct coupling. When applying reduced-pressure to thetissue site 102, theabsorbent pouch 114 may receive and retain fluids from thetissue site 102. - In one embodiment, the sealing
member 154 is a sealing ring that provides a pneumatic seal between thepump 108 and theabsorbent pouch 114. One side of the sealing ring may be bonded to thesubstrate 132 to which thepump 108 is mounted and the other side of the sealing ring may be bonded to theabsorbent pouch 114. - The
absorbent pouch 114 applies reduced pressure from thepump 108 to thetissue site 102. Theabsorbent pouch 114 includes amanifold layer 124 formed from a manifold material and is applied adjacent to thetissue site 102 to distribute reduced pressure. Generally, a manifold is a substance or structure that assists in applying reduced pressure to, delivering fluids to, or removing fluids from atissue site 102. Themanifold layer 124 typically includes a plurality of flow channels or pathways that distribute fluids provided to and removed from thetissue site 102 around themanifold layer 124. In one illustrative embodiment, the flow channels or pathways are interconnected to improve distribution of fluids provided to or removed from thetissue site 102. Themanifold layer 124 may be a biocompatible material that is capable of being placed in contact with thetissue site 102 and distributing reduced pressure to thetissue site 102. Examples of materials used to form themanifold layer 124 may include without limitation the following: materials that have structural elements arranged to form flow channels, e.g., cellular foam, open-cell foam, porous tissue collections, liquids, gels, and foams that include, or cure to include, flow channels; foam; gauze; felted mat; or any other material suited to a particular biological application. - In one embodiment, the
manifold layer 124 is a porous foam and includes a plurality of interconnected cells or pores that act as flow channels. The porous foam may be a polyurethane, open-cell, reticulated foam such as GranuFoam® material available from Kinetic Concepts, Incorporated of San Antonio, Tex. In some situations, themanifold layer 124 may also be used to distribute fluids such as medications, antibacterials, growth factors, and various solutions to thetissue site 102. Other layers may be included in or onmanifold layer 124, such as absorptive materials, wicking materials, hydrophobic materials, and hydrophilic materials. - In one embodiment, the
manifold layer 124 distributes reduced pressure generated by thepump 108 and may draw exudate from thewound 104. To retain the exudate, themanifold layer 124 is coupled to anabsorbent layer 110 that functions to receive and retain fluids such as exudate from thetissue site 102. Theabsorbent layer 110 may be made from any material capable of absorbing liquid. For example, theabsorbent layer 110 may be made from super absorbent fibers. The super absorbent fibers may retain or bond to the liquid in conjunction with a physical or chemical change to the fibers. In one non-limiting example, the super absorbent fiber may include the Super Absorbent Fiber (SAF) material from Technical Absorbents, Ltd. of Grimsby, United Kingdom. Theabsorbent layer 110 may be a sheet or mat of fibrous material in which the fibers absorb liquid from thetissue site 102. The structure of theabsorbent layer 110 that contains the fibers may be either woven or non-woven. The fibers in theabsorbent layer 110 may gel upon contact with the liquid, thereby trapping the liquid. Spaces or voids between the fibers may allow reduced pressure that is applied to theabsorbent layer 110 to be transferred within and through theabsorbent layer 110. - To prevent liquid (e.g., exudate) from escaping the
absorbent pouch 114 and entering theelectronics pouch 116, a liquid-air separator 112, e.g., a hydrophobic filter, may be placed betweenabsorbent layer 110 and a first cover of theabsorbent pouch 114. In such an embodiment, thefirst cover 126 of theabsorbent pouch 114 is coupled about the perimeter of the sealingmember 154 to form a fluid seal. - In an embodiment, an intermediate manifold may be applied between the reduced-
pressure dressing 106 and a portion of thetissue site 102. The intermediate manifold may be constructed from bioresorbable materials that may remain in a patient's body following use of the reduced-pressure dressing 106. Suitable bioresorbable materials may include, without limitation, a polymeric blend of polylactic acid (PLA) and polyglycolic acid (PGA). The polymeric blend may also include without limitation polycarbonates, polyfumarates, and capralactones. The intermediate manifold may further serve as a scaffold for new cell-growth, or a scaffold material may be used in conjunction with the intermediate manifold to promote cell-growth. A scaffold is a substance or structure used to enhance or promote the growth of cells or formation of tissue, such as a three-dimensional porous structure that provides a template for cell growth. Illustrative examples of scaffold materials include calcium phosphate, collagen, PLA/PGA, coral hydroxy apatites, carbonates, or processed allograft materials. In an embodiment, the reduced-pressure dressing 106 also includes an interface layer, or comfort layer, for placing between thetissue site 102 and themanifold layer 124. - The
absorbent pouch 114 maintains a fluid coupling with thetissue site 102 to apply reduced-pressure. As such, the perimeter of theabsorbent pouch 114 may be coupled to thetissue site 102 to form a sealed space. This coupling creates a fluid seal around thetissue site 102 that may be achieved by coupling thefirst cover 126 of theabsorbent pouch 114 to thetissue site 102 using an attachment device. In such an embodiment, thefirst cover 126 is coupled to themanifold layer 124 or a comfort layer so that theabsorbent layer 110 will maintain structural integrity when removed from thetissue site 102. In another embodiment, thefirst cover 126 is coupled to asecond cover 128 in the manner described above with regard to thefirst electronics cover 120 and second electronics cover 122 of theelectronics pouch 116. In an embodiment, thesecond cover 128 is coupled to thetissue site 102 to create the fluid seal when the reduced-pressure dressing 106 is applied to thetissue site 102. Upon removal of the reduced-pressure dressing 106 from thetissue site 102, the coupling between thefirst cover 126 andsecond cover 128 prevents the layers of theabsorbent pouch 114 from separating so that theabsorbent pouch 114 may be discarded as a unit. - To maintain the fluid seal, the
first cover 126 andsecond cover 128 of theabsorbent pouch 114, and thefirst electronics cover 120 and second electronics cover 122 of theelectronics pouch 116 may be formed from an impermeable or semi-permeable, elastomeric material. Elastomeric materials have the properties of an elastomer or, more generally, a polymeric material that has rubber-like properties. More specifically, most elastomers have ultimate elongations greater than 100% and a significant amount of resilience. The resilience of a material refers to the material's ability to recover from an elastic deformation. Examples of elastomers include, but are not limited to, natural rubbers, polyisoprene, styrene butadiene rubber, chloroprene rubber, polybutadiene, nitrile rubber, butyl rubber, ethylene propylene rubber, ethylene propylene diene monomer, chlorosulfonated polyethylene, polysulfide rubber, polyurethane (PU), EVA film, co-polyester, and silicones. Additional, specific examples of dressing sealing member materials include a silicone drape, 3M Tegaderm® drape, polyurethane (PU) drape such as one available from Avery Dennison Corporation of Pasadena, Calif. The reduced-pressure dressing forms a sealed space over thetissue site 102, which may or may not contain thepump 108. The elastomeric material may be a tin, flexible elastomeric film. - An
attachment device 162 may be used to couple thefirst cover 126 orsecond cover 128 to the patient's epidermis or another intermediate layer, such as a gasket or additional sealing device. Theattachment device 162 may take numerous forms. For example, theattachment device 162 may be a medically acceptable, pressure-sensitive adhesive that extends about a periphery or all of the first cover 126 (or second cover 128) or covers at least a portion of a patient-facing side of the reduced-pressure dressing 106 over theepidermis 156. - As noted above, the reduced-pressure dressing 106 includes the
removable coupling 118 between theelectronics pouch 116 and theabsorbent pouch 114. Theremovable coupling 118 allows a caregiver to separate theelectronics pouch 116 from theabsorbent pouch 114 by exerting a force on a portion of theelectronics pouch 116, such astab 130. An example of such a removable coupling is described in more detail with regard toFIGS. 2-4 . - Turning now to
FIGS. 2-4 , the reduced-pressure dressing 206 includes aremovable coupling 218 that facilitates the separation of theelectronics pouch 216 from theabsorbent pouch 214 after use. Theremovable coupling 218 includes afirst bond 236 and asecond bond 238 offset from thefirst bond 236. Thefirst bond 236 andsecond bond 238 may be any suitable type of joining technology, bond or coupling, including a high frequency weld, an ultrasonic weld, a heat weld, an adhesive bond, and a molded part line. In one embodiment, thefirst bond 236 couples asecond electronics cover 222 to afirst cover 226 of anabsorbent pouch 214. Thesecond bond 238 is offset from thefirst bond 236 and further from theperimeter 278 of the reduced-pressure dressing 206 than thefirst bond 236. Thefirst bond 236 should be strong enough so that unintended separation of theelectronics pouch 216 from theabsorbent pouch 214 does not occur. Thefirst bond 236 may be a weld or other joint that provides a pneumatic seal, but a pneumatic seal between the pouches may instead be provided by another component or weld that is within the boundary of thefirst bond 236, such as a sealingmember 254. Aperforation 234 extends through thefirst electronics cover 220 and second electronics cover 222 between thefirst bond 236 andsecond bond 238, i.e., inside of thefirst bond 236 but outside of thesecond bond 238. Theperforation 234 provides a separation line where thefirst electronics cover 220 and second electronics cover 222 can be torn to separate theelectronics pouch 216 from theabsorbent pouch 214. To facilitate separation of theelectronics pouch 216 from theabsorbent pouch 214, the first electronics cover 220 may include atab 230 bonded to the first electronics cover 220 using any of the bond types described above, or formed integrally to thefirst electronics cover 220. Alternatively, the first electronics cover 220 may include a hole that allows a separation force to be exerted on theelectronics pouch 216. In one embodiment, pulling thetab 230 causes a tear to develop and propagate along the weakened path of theperforation 234 until theelectronics pouch 216 separates from theabsorbent pouch 214. - In one embodiment, the
first bond 236 couples the second electronics cover 222 to both thefirst electronics cover 220 andfirst cover 226. In another embodiment, thefirst bond 236 couples the first electronics cover 220 to thesecond electronics cover 222. In such embodiments, the second electronics cover 222 couples to thefirst cover 226 at any suitable location that is outside of theperforation 234 to preserve the coupling of theelectronics pouch 216 to theabsorbent pouch 214 until theelectronics pouch 216 is torn along theperforation 234. - The dimensions of the
perforation 234 are dependent on the material used to manufacture theelectronics pouch 216 orabsorbent pouch 214 as well as the location of theperforation 234. Theperforation 234 should weaken the material so that the strength of the perforated area is significantly less than the tear strength of the pouch material. In an embodiment where the material is Exopack DEV 09-80A or Inspire 70980, theperforation 234 may have the dimensions of 0.1 mm land and between 0.1 mm and 0.5 mm space. -
FIG. 3 illustrates a possible arrangement of thefirst bond 236,perforation 234, andsecond bond 238 andFIG. 4 shows how theelectronics pouch 216 separates from theabsorbent pouch 214 after being torn along theperforation 234. When separated, the portion of the reduced-pressure dressing 206 that retains theabsorbent pouch 214 has afirst perforation line 234 a and theelectronics pouch 216 has asecond perforation line 234 b indicating the points of separation. In the illustrative embodiment ofFIGS. 2-4 , the sealingmember 254 is shown as being coupled to the patient-facing side of theelectronics pouch 216 and releasably coupled to theabsorbent pouch 214. In another embodiment, however, the sealingmember 254 is coupled to theabsorbent pouch 214 and releasably coupled to theelectronics pouch 216. - In an embodiment, the sealing
member 254 is a sealing ring, and an adhesive is used to couple the sealing ring to thesubstrate 232 of thepump 208 or to thefirst cover 226 of theabsorbent pouch 214. The properties of the adhesive applied to the surfaces of the sealing ring may be altered so that when the pouches are separated, the sealing ring remains adhered to either thesubstrate 232 or thefirst cover 226. If the sealing ring is attached by welding, the seal ring itself can have a weakened area to facilitate tearing to separate the sealing ring from theelectronics pouch 216 orabsorbent pouch 214 when theelectronics pouch 216 is removed. The sealing ring may then be disposed appropriately. Adhesives that may be used to adhere the sealing ring to thesubstrate 232 of thefirst cover 226 Acrylic Pressure Sensitive Adhesives (PSA) based such as 3M 927, or a UV liquid adhesive such as Dymax 1201-M-SC. - The sealing
member 254 may be a single flexible material that has adhesive coating on each side to couple to theelectronics pouch 216 andabsorbent pouch 214. The sealingmember 254 also provides a fluid seal between theelectronics pouch 216 andabsorbent pouch 214. The flexible material may be a closed cell foam, such as a foam manufactured from neoprene or ethylene-vinyl acetate (EVA). Additionally, the flexible material may provide a level of padding between theelectronics pouch 216 andabsorbent pouch 214, thereby adding flexibility to the reduced-pressure dressing 206. In an embodiment, the sealing member material may be a solid elastomeric material, such as a thermoplastic elastomer (TPE), or a rigid material. Where an adhesive is used to hold the sealingmember 254 in place, the adhesive properties can be altered between the two sides of the sealingmember 254 so that on separation, the sealingmember 254 remains coupled to either theelectronics pouch 216 or theabsorbent pouch 214. - In another embodiment, the
electronics pouch 216 couples directly to theabsorbent pouch 214. In such an embodiment, a portion of theelectronics pouch 216 or theabsorbent pouch 214 may include a breakaway feature, such as a weakened area in the pouch material or a breakaway feature in thesubstrate 232 to facilitate separation of the pouches. - Together,
FIGS. 2-4 show that a caregiver may separate theelectronics pouch 216 from theabsorbent pouch 214 by grasping thetab 230 and exerting a force to tear thefirst electronics cover 220 and second electronics cover 222 around the perimeter of theelectronics pouch 216. After generating the tear, theelectronics pouch 216 may be grasped and pulled to apply pressure to the sealingmember 254, which may be a sealing ring. Once the sealingmember 254 is separated from theelectronics pouch 216, theelectronics pouch 216 is completely free from theabsorbent pouch 214 and the pouches may be discarded separately. -
FIG. 5 shows another illustrative embodiment of a reduced-pressure dressing 306 that is similar in many respects to the dressings ofFIGS. 1-4 but omits a second electronics cover. In the embodiment, an upper layer of theabsorbent pouch 314, such as the a liquid-air separator 312, is coupled to thefirst cover 326 by afirst bond 336. Inside of the first bond, thefirst cover 326 includes aperforation 334. Inside of theperforation 334, thefirst cover 326 is coupled to the first electronics cover 320 by asecond bond 338. In this embodiment, thefirst cover 326 is also coupled to thesubstrate 332 that forms a portion of patient-facing side of theelectronics pouch 316. Similar to the embodiments ofFIGS. 1-4 , the reduced-pressure dressing 306 may be torn along theperforation 334 to separate theelectronics pouch 316 from theabsorbent pouch 314. In this embodiment, thetab 330 may merely be an extension of thefirst electronics cover 320. -
FIGS. 6A and 6B show another illustrative embodiment of a reduced-pressure dressing 406 having anelectronics pouch 416 attached to anabsorbent pouch 414 by aremovable coupling 418. In the embodiment, thefirst cover 426 of theabsorbent pouch 414 is coupled to a proximate side of the sealingmember 454. The opposing side of the sealingmember 454 is coupled to the second electronics cover 422 or thesubstrate 432 of theelectronics pouch 416. In addition, thefirst cover 426 and first electronics cover 420 (or second electronics cover 422) are coupled to one another by theremovable coupling 418, which is anintermediate cover member 450. Theintermediate cover member 450 may include a perforation or be formed of a material that is easier to tear than the material that forms the pouches to facilitate separation of theelectronics pouch 416 from theabsorbent pouch 414. - In an embodiment, the
intermediate cover member 450 provides a fluid seal between theelectronics pouch 416 and theabsorbent pouch 414, thereby alleviating the need for a sealingmember 454. Theintermediate cover member 450 may add flexibility between theabsorbent pouch 414 andelectronics pouch 416 in such an embodiment. Theintermediate cover member 450 is bonded to thesubstrate 432 to which thepump 408 is mounted and bonded or welded to thefirst cover 426 of theabsorbent pouch 414. The material that forms theintermediate cover member 450 is selected such that, when theelectronics pouch 416 is separated from theabsorbent pouch 414, theintermediate cover member 450 will break before the integrity of either pouch is compromised. In another embodiment, the separation occurs at either the bond between theintermediate cover member 450 and theabsorbent pouch 414 or the bond between theintermediate cover member 450 and theelectronics pouch 416. - In one embodiment, the sealing
member 454 is formed from afirst sealing connector 442 coupled to thesubstrate 432 of theelectronics pouch 416 and asecond sealing connector 444 coupled to theabsorbent pouch 414. Thefirst sealing connector 442 is releasably coupled to thesecond sealing connector 444. AsFIG. 6B shows, the releasable coupling between thefirst sealing connector 442 andsecond sealing connector 444 results in thefirst sealing connector 442 remaining coupled to theelectronics pouch 416 and thesecond sealing connector 444 remaining coupled to theabsorbent pouch 414 when the pouches are separated. In one embodiment the sealingmember 454 orsecond sealing connector 444 includes additional elements, such as a liquid-air separator 446 and anodor filter 448. Including the liquid-air separator 446 within the sealingmember 454 may alleviate the need for such an element in the absorbent pouch, enabling a smaller part to perform the function of preventing liquids (e.g., exudate) from entering theelectronics pouch 416. Similarly, the sealingmember 454 may include theodor filter 448, which may be a charcoal filter, thereby alleviating the need to install such an element in another portion of the reduced-pressure dressing 406. The sealingmember 454 may be formed from a polymer, such as a polyvinyl chloride (PVC) or acrylonitrile butadiene styrene (ABS) polymer. In an embodiment, the sealingmember 454 may instead be formed from polyurethane or another suitable material that is compatible with the pouch cover material and weldable using a high-frequency welding process. In one embodiment, the sealingmember 454 couples to the second electronics cover 422 or directly to thesubstrate 432 using an adhesive. - In one embodiment, a breakable connection piece is securely bonded to both the
electronics pouch 416 andabsorbent pouch 414 to serve the function of both a sealingmember 454 andintermediate cover member 450. In such an embodiment, the pouches may be separated by breaking the breakable connection piece. Such a breakable connection piece may be manufactured from a plastic molding having a weakened breakaway area that causes the breakable connection piece to break in a predictable and controllable manner. The breakable connection piece may be made from an injection molded thermoplastic polyurethane (TPU), such as Pellethane® 2363-80AE having a durometer of 80 on the Shore A scale. The thickness of the weakened area may be in the range of 0.05 mm to 0.08 mm, thereby enabling a controlled tear, or break, to be induced without risking damage or undesirable disassembly of theelectronics pouch 416 orabsorbent pouch 414. In an embodiment, the breakable connection piece contains an odor filter and a liquid-air separator. The breakable connection piece may also be manufactured from a porous polymer, e.g., a sintered polymer, that has been treated to provide liquid and odor blocking functions. For example, the breakable connection piece may include hydrophobic materials for liquid separation and activated carbon particles for odor control. In the case of a sintered polymer material, the breakable connection piece would not include an aperture, but would be a gas permeable structure having a sealed outer surface such that gas would be pulled through the breakable connection piece to transmit reduced-pressure. In such an embodiment, the outer surface of the breakable connection piece formed from the sintered polymer should be coated with a gas impermeable coating to provide a seal. - Where the
intermediate cover member 450 is a breakable connection piece having a breakaway feature, the breakable connection piece may include an electrical connection. The electrical connection may electrically couple one or more sensors in theabsorbent layer 410 to the processor of theelectronics pouch 416. In such an embodiment, the reduced-pressure dressing 406 may include sensors to measure the fluid capacity of the dressing, the mechanical or pneumatic pressure at the tissue site, the pH of the wound, and other characteristics of the tissue site. The electrical coupling may also be used to provide power to a therapeutic system mounted within theabsorbent layer 410 that requires power or monitoring, such as a wound camera or electrical stimulation system. In such an embodiment, a RF device, such as a RFID antenna, may be mounted in the reduced-pressure dressing 406 and the breakable connection piece may provide additional space to mount related electrical components. In addition, the breakable connection piece may provide multiple channels or lumens from theelectronics pouch 416 to theabsorbent pouch 414, which may enable the monitoring of pressure in specific areas of the reduced-pressure dressing. In such an embodiment, a TRAC system may be used to determine absorbent saturation or other characteristics of a tissue site where substances are being delivered to a wound. In such an embodiment, the reduced-pressure dressing may be configured to deliver anti-microbial agents, analgesics, and cleansing solutions. - In another embodiment, the
intermediate cover member 450 is an adhesive layer that provides a fluid seal between theelectronics pouch 416 andabsorbent pouch 414. The adhesive layer may be configured to allow theelectronics pouch 416 to be separated from theabsorbent pouch 414 by peeling the pouches apart. - Alternatively, the
intermediate cover member 450 may be a film joined to theelectronics pouch 416 andabsorbent pouch 414 by a suitable method, such as bonding or welding. The film may be manufactured so that the film is weaker than the adjacent materials, thereby allowing the film to break instead of theadjacent electronics pouch 416 andabsorbent pouch 414 as the pouches are pulled apart. Alternatively, a separation mechanism such as a string or strip of material is included beneath the film, such that pulling the string outward will cause the string or strip to unwind and tear the film to facilitate separation of the pouches. -
FIG. 7 shows another illustrative embodiment of a reduced-pressure dressing 506 that includes anelectronics pouch 516 and anabsorbent pouch 514. In the embodiment, reduced-pressure is transmitted from apump 508 of theelectronics pouch 516 to theabsorbent pouch 514 via sealingmember 554. Theelectronics pouch 516 is coupled to theabsorbent pouch 514 by anintermediate cover member 550 that is manufactured from multiple parts, such as a first cover connector 562 and asecond cover connector 564. The first cover connector 562 andsecond cover connector 564 are formed from different polymers so that adhesion between the first cover connector 562 andsecond cover connector 564 is strong enough to provide a fluid seal but weak enough to be easily broken. For example, if the first cover connector 562 is fabricated from polyurethane, then the second cover connector may be formed from polypropylene or high-impact polystyrene. In addition, thesecond cover connector 564 may be formed from polyurethane or another suitable material that is compatible with the pouch cover material and weldable using a HF welding process. In an embodiment, a fluid seal between the first cover connector 562 andsecond cover connector 564 is obtained by an interference fit between the connectors. As such, the first cover connector 562 and second cover connector 546 may be mating parts having a snap fit or twist-lock feature with sealing surfaces to maintain a fluid seal. The first cover connector 562 is coupled to thefirst cover 526 of theabsorbent pouch 514 by an adhesive or weld, or by forming the first cover connector integrally to thefirst cover 526. Thesecond cover connector 564 couples to theelectronics pouch 516 in a similar manner. - In an embodiment having the first cover connector 562 and
second cover connector 564, one of the parts, e.g., the first cover connector 562 may be manufactured by injection molding. Thesecond cover connector 564 is then combined with the first cover connector 562 using an overmolding process. The overmolding process allows different materials to be used that are optimized for the joining process used at each interface. For example, the first cover connector 562 may be suitable for welding to a polymer surface of theabsorbent pouch 514 while thesecond cover connector 564 is better suited for adhesive bonding to a surface of the electronics pouch 516 (e.g., to a polyimide or phenolic PCB substrate). - To form the
second cover connector 564, the first cover connector 562 is installed in a mold, which is used to form thesecond cover connector 564 by overmolding thesecond cover connector 564 to the first cover connector 562. The overmolding process results in a part line 566 at the junction of the first cover connector 562 andsecond cover connector 564. The part line 566 may be formed such that when a separation force is applied to the pouches, theelectronics pouch 516 separates from theabsorbent pouch 514 along the part line 566. The part line 566 may be a flat surface or may include a mechanical interlock feature that enhances sealing. Where the fluid seal is enhanced by an interlock feature, the polymeric bond between the first cover connector 562 andsecond cover connector 564 is less important for the purposes of creating a fluid seal, and a weaker bond may be acceptable. As such, the first cover connector 562 and thesecond cover connector 564 may be formed from dissimilar materials that will not form a strong bond to one another. Also, a coating may be applied to the first cover connector 562 along the part line 566 to prevent thesecond cover connector 564 from permanently bonding to the first cover connector 562. In this way, the first cover connector 562 may be removably coupled to thesecond cover connector 564 to maintain a fluid seal until theelectronics pouch 516 is separated from theabsorbent pouch 514. - A fluid seal between the first cover connector 562 and
second cover connector 564 may be more easily obtained by using an overmolding process than another manufacturing process because manufacturing tolerances and dimensional variations at the interface are negated by the overmolding process. The overmolding process also facilitates the joining of dissimilar materials. For example, in an embodiment in which there is a difference in hardness between the first cover connector 562 and thesecond cover connector 564, the connector formed from the softer polymer is formed using the overmolding process, while the opposing connector is formed using the injection molding process. - The use of dissimilar materials may also facilitate separation. Where the first cover connector 562 and
second cover connector 564 include mechanical interlocking features, the softer connector may be more easily deformed to separate from the harder connector. In another embodiment both the first cover connector 562 andsecond cover connector 564 are injection molded and assembled together to provide a sealed coupling. In embodiments in which a more rigid part is manufactured from a material other than a thermoplastic (e.g., thermoset polymer), other manufacturing techniques may be employed. - In an embodiment, the
absorbent pouch 514 remains in place at a tissue site while theelectronics pouch 516 is removed to, for example, renew the power source of thepump 508. The power source of thepump 508 may be replaced within theelectronics pouch 516 and theelectronics pouch 516 may be reapplied or replaced with anew electronics pouch 516 to extend the life of the reduced-pressure dressing 506. -
FIGS. 8A and 8B show an embodiment of a reduced-pressureddressing 606 having an arcuate shape. Aside from the arcuate shape, the reduced-pressure dressing 606 is generally analogous to the dressing ofFIG. 1 . For example, the reduced-pressure dressing 606 includes anabsorbent pouch 614 having afirst cover 626. Theabsorbent pouch 614 receives reduced-pressure from a pump that is housed within anelectronics pouch 616. Theelectronics pouch 616 is removably coupled to absorbent pouch at afirst bond 636 and asecond bond 638. Adjacent thesecond bond 638, the reduced-pressure dressing 606 includes aperforation 634 that facilitates the separation of theabsorbent pouch 614 from theelectronics pouch 616. Thefirst cover 620 of theelectronics pouch 616 includes atab 630 that can be pulled to initiate a tear along theperforation 634 to separate the pouches. -
FIG. 9 shows an exploded view of a reduced-pressure dressing 706 that contains additional layers but is similar in many respects to the dressings discussed above. The reduced-pressure dressing 706 is shown in a rectangular form but may be formed to have any suitable shape for application to a tissue site. For example, the reduced-pressure dressing may be shaped to resemble the reduced-pressure dressing 606 ofFIGS. 8A and 8B . - The reduced-pressure dressing 706 includes an optional
intermediate manifold 768 that may be placed adjacent the tissue site, as discussed above. The reduced-pressure dressing 706 includes afirst cover 726 and asecond cover 728. Thesecond cover 728 has afirst side 780 and a second, patient-facingside 781. The second, patient-facingside 781 may be coated with a releasable adhesive to facilitate application to a tissue site. Thesecond cover 728 also includes atreatment aperture 782 for placing over a portion of the tissue site (e.g., a wound) that receives reduced pressure. The reduced-pressure dressing 706 also includes amanifold layer 724, which is an internal distribution manifold having afirst side 783 and a second, patient-facingside 784. In use, themanifold layer 724 distributes reduced-pressure to the tissue site. The second, patient-facingside 784 of themanifold layer 724 is coupled to thefirst side 780 of thesecond cover 728. Anabsorbent layer 710, which functions to receive and retain fluids from a tissue site, is coupled to themanifold layer 724. - A
diverter layer 770 is coupled to theabsorbent layer 710. Thediverter layer 770 is disposed adjacent to theabsorbent layer 710 and themanifold layer 724. Thediverter layer 770 is formed from a liquid impermeable material but contains a plurality ofapertures 785. The plurality ofapertures 785 allow reduced pressure to be transmitted through thediverter layer 770 at desired locations. Thediverter layer 770 helps control the pattern of reduced pressure as applied to theabsorbent layer 710. The reduced pressure is distributed to thediverter layer 770 by asecond manifold layer 772 that is coupled to thediverter layer 770. Theapertures 785 may be arranged in a pattern for applying the reduced pressure to portions of theabsorbent layer 710 to enhance the capability of theabsorbent layer 710 to continue transferring reduced pressure to the tissue site as theabsorbent layer 710 absorbs more fluid from the tissue site. Thediverter layer 770 acts in conjunction with thesecond manifold layer 772 to ensure that the absorption capabilities and absorption efficiency of theabsorbent layer 710 are increased relative to anabsorbent layer 710 that is not used in conjunction with adiverter layer 770. By providing better distribution of liquid throughout theabsorbent layer 710, thediverter layer 770 also increases the effective capacity and treatment time of the reduced-pressure dressing 706. - The
diverter layer 770 may be made from any material that enhances the reduced pressure transmission and storage capabilities of an adjacent absorbent layer. For example, thediverter layer 770 may be made from a material that is substantially impermeable to liquid and gas and that diverts the reduced pressure to pass throughapertures 785. Alternatively or in addition, the material from which thediverter layer 770 is made may have a predetermined moisture vapor transfer rate that is consistent with gas permeability. In either example, thediverter layer 770 may still include a pattern of apertures for transmitting a greater volume of liquid or gas than that permitted by a gas-permeable material not having apertures. It should be noted, however, that permeability of thediverter layer 770 to gas but not liquid may result in increased transmission of reduced pressure through the dressing while still directing liquid flow around or near the perimeter of thediverter layer 770. - In this embodiment, the reduced-pressure dressing 706 includes a liquid-
air separator 712 coupled to thesecond manifold layer 772 and thefirst cover 726, which is coupled about the perimeter to thesecond cover 728. Thefirst cover 726 includes anaperture 788 to receive reduced pressure. Together, thefirst cover 726 andsecond cover 728 form afirst envelope 786 enclosing themanifold layer 724,absorbent layer 710,diverter layer 770,second manifold layer 772, and liquid-air separator 712. - To generate reduced pressure, the reduced-pressure dressing 706 includes a
pump 708. The pump is mounted to asubstrate 732 and coupled to aprocessor 760 and apower source 774. Additional electronic components may be coupled to thepump 708,processor 760, orpower source 774 as desired. Thesubstrate 732 is enclosed between afirst electronics cover 720, which is coupled to asecond electronics cover 722 to form asecond envelope 787. The first electronics cover 722 also includes avent 776 to fluidly couple an exhaust of thepump 708 to the external environment and an odor filter may be installed between the exhaust of thepump 708 and thevent 776 to prevent odor from a wound from escaping the reduced-pressure dressing 706. Thesubstrate 732 and second electronics cover 722 also include apertures to facilitate the transmission of reduced pressure to thefirst envelope 786. - The
second envelope 787 is removably coupled to thefirst envelope 786 using a removable coupling that provides a fluid seal. For example, a portion of the second electronics cover 722 may be coupled to a portion of thesecond cover 728. Optionally, a sealingmember 754 provides a sealed fluid path between thesecond envelope 787 and thefirst envelope 786. The sealingmember 754 includes an aperture for transmitting reduced-pressure generated by thepump 708 to the layers of thefirst envelope 786 for application to the tissue site. - Although the present invention and its advantages have been disclosed in the context of certain illustrative, non-limiting embodiments, it should be understood that various changes, substitutions, permutations, and alterations can be made without departing from the scope of the invention as defined by the appended claims. It will be appreciated that any feature that is described in connection to any one embodiment may also be applicable to any other embodiment.
- It will be understood that the benefits and advantages described above may relate to one embodiment or may relate to several embodiments. It will further be understood that reference to “an” item refers to one or more of those items.
- The steps of the methods described herein may be carried out in any suitable order, or simultaneously where appropriate.
- Where appropriate, aspects of any of the embodiments described above may be combined with aspects of any of the other embodiments described to form further examples having comparable or different properties and addressing the same or different problems.
- It will be understood that the above description of preferred embodiments is given by way of example only and that various modifications may be made by those skilled in the art. The above specification, examples and data provide a complete description of the structure and use of exemplary embodiments of the invention. Although various embodiments of the invention have been described above with a certain degree of particularity, or with reference to one or more individual embodiments, those skilled in the art could make numerous alterations to the disclosed embodiments without departing from the scope of the claims.
Claims (24)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/367,600 US20190262514A1 (en) | 2012-03-28 | 2019-03-28 | Reduced-Pressure Systems, Dressings, And Methods Facilitating Separation Of Electronic And Clinical Component Parts |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261616901P | 2012-03-28 | 2012-03-28 | |
PCT/US2013/034472 WO2013149078A1 (en) | 2012-03-28 | 2013-03-28 | Reduced-pressure systems, dressings, and methods facilitating separation of electronic and clinical component parts |
US201414386444A | 2014-09-19 | 2014-09-19 | |
US16/367,600 US20190262514A1 (en) | 2012-03-28 | 2019-03-28 | Reduced-Pressure Systems, Dressings, And Methods Facilitating Separation Of Electronic And Clinical Component Parts |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2013/034472 Division WO2013149078A1 (en) | 2012-03-28 | 2013-03-28 | Reduced-pressure systems, dressings, and methods facilitating separation of electronic and clinical component parts |
US14/386,444 Division US10286129B2 (en) | 2012-03-28 | 2013-03-28 | Reduced-pressure systems, dressings, and methods facilitating separation of electronic and clinical component parts |
Publications (1)
Publication Number | Publication Date |
---|---|
US20190262514A1 true US20190262514A1 (en) | 2019-08-29 |
Family
ID=48096312
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/386,444 Expired - Fee Related US10286129B2 (en) | 2012-03-28 | 2013-03-28 | Reduced-pressure systems, dressings, and methods facilitating separation of electronic and clinical component parts |
US16/367,600 Abandoned US20190262514A1 (en) | 2012-03-28 | 2019-03-28 | Reduced-Pressure Systems, Dressings, And Methods Facilitating Separation Of Electronic And Clinical Component Parts |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/386,444 Expired - Fee Related US10286129B2 (en) | 2012-03-28 | 2013-03-28 | Reduced-pressure systems, dressings, and methods facilitating separation of electronic and clinical component parts |
Country Status (7)
Country | Link |
---|---|
US (2) | US10286129B2 (en) |
EP (1) | EP2830555B1 (en) |
JP (1) | JP6238417B2 (en) |
CN (1) | CN104168865B (en) |
AU (1) | AU2013237989B2 (en) |
CA (1) | CA2864428A1 (en) |
WO (1) | WO2013149078A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022271449A1 (en) * | 2021-06-25 | 2022-12-29 | Aatru Medical, LLC | Dressing having metal coating |
Families Citing this family (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
GB0325129D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus in situ |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US10058642B2 (en) | 2004-04-05 | 2018-08-28 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
US7753894B2 (en) | 2004-04-27 | 2010-07-13 | Smith & Nephew Plc | Wound cleansing apparatus with stress |
CN101257875A (en) | 2005-09-06 | 2008-09-03 | 泰科保健集团有限合伙公司 | Self contained wound dressing with micropump |
US7779625B2 (en) | 2006-05-11 | 2010-08-24 | Kalypto Medical, Inc. | Device and method for wound therapy |
CA2872297C (en) | 2006-09-28 | 2016-10-11 | Smith & Nephew, Inc. | Portable wound therapy system |
US8505540B2 (en) | 2007-11-13 | 2013-08-13 | Apnicure, Inc. | Methods and systems for improving airway patency |
EP3360519B1 (en) | 2007-11-21 | 2020-11-18 | Smith & Nephew plc | Wound dressing |
MX2010005553A (en) | 2007-11-21 | 2010-06-01 | Smith & Nephew | Wound dressing. |
GB0722820D0 (en) | 2007-11-21 | 2008-01-02 | Smith & Nephew | Vacuum assisted wound dressing |
GB0723855D0 (en) | 2007-12-06 | 2008-01-16 | Smith & Nephew | Apparatus and method for wound volume measurement |
EP3409304B1 (en) | 2008-03-05 | 2022-07-27 | 3M Innovative Properties Company | Dressing for applying reduced pressure to and collecting and storing fluid from a tissue site |
US9199012B2 (en) | 2008-03-13 | 2015-12-01 | Smith & Nephew, Inc. | Shear resistant wound dressing for use in vacuum wound therapy |
US8814842B2 (en) | 2010-03-16 | 2014-08-26 | Kci Licensing, Inc. | Delivery-and-fluid-storage bridges for use with reduced-pressure systems |
GB201015656D0 (en) | 2010-09-20 | 2010-10-27 | Smith & Nephew | Pressure control apparatus |
RU2597393C2 (en) | 2010-11-25 | 2016-09-10 | СМИТ ЭНД НЕФЬЮ ПиЭлСи | Composition i-ii, article containing same and use thereof |
GB201020005D0 (en) | 2010-11-25 | 2011-01-12 | Smith & Nephew | Composition 1-1 |
GB201108229D0 (en) | 2011-05-17 | 2011-06-29 | Smith & Nephew | Tissue healing |
US9084845B2 (en) | 2011-11-02 | 2015-07-21 | Smith & Nephew Plc | Reduced pressure therapy apparatuses and methods of using same |
US20150159066A1 (en) | 2011-11-25 | 2015-06-11 | Smith & Nephew Plc | Composition, apparatus, kit and method and uses thereof |
US10940047B2 (en) | 2011-12-16 | 2021-03-09 | Kci Licensing, Inc. | Sealing systems and methods employing a hybrid switchable drape |
AU2012352000B2 (en) | 2011-12-16 | 2017-06-29 | Solventum Intellectual Properties Company | Releasable medical drapes |
AU2013234034B2 (en) | 2012-03-12 | 2017-03-30 | Smith & Nephew Plc | Reduced pressure apparatus and methods |
WO2013140255A1 (en) | 2012-03-20 | 2013-09-26 | Smith & Nephew Plc | Controlling operation of a reduced pressure therapy system based on dynamic duty cycle threshold determination |
US9427505B2 (en) | 2012-05-15 | 2016-08-30 | Smith & Nephew Plc | Negative pressure wound therapy apparatus |
EP3650055A1 (en) | 2012-05-23 | 2020-05-13 | Smith & Nephew plc | Apparatuses and methods for negative pressure wound therapy |
RU2015106112A (en) | 2012-08-01 | 2016-09-20 | СМИТ ЭНД НЕФЬЮ ПиЭлСи | Wound dressing |
EP3406231B1 (en) | 2012-08-01 | 2022-04-13 | Smith & Nephew plc | Wound dressing and method of treatment |
CN111991092A (en) | 2012-11-16 | 2020-11-27 | 凯希特许有限公司 | Medical drape having patterned adhesive layer and method of making same |
GB201317746D0 (en) | 2013-10-08 | 2013-11-20 | Smith & Nephew | PH indicator |
US10695226B2 (en) | 2013-03-15 | 2020-06-30 | Smith & Nephew Plc | Wound dressing and method of treatment |
JP6715598B2 (en) | 2013-03-15 | 2020-07-01 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Wound dressing and treatment method |
US20160120706A1 (en) | 2013-03-15 | 2016-05-05 | Smith & Nephew Plc | Wound dressing sealant and use thereof |
TWI805996B (en) | 2013-08-05 | 2023-06-21 | 美商扭轉生物科技有限公司 | De novo synthesized gene libraries |
EP3062753B1 (en) | 2013-10-28 | 2018-11-21 | KCI Licensing, Inc. | Hybrid sealing tape |
EP3656362A1 (en) | 2013-10-30 | 2020-05-27 | KCI Licensing, Inc. | Condensate absorbing and dissipating system related application |
TR201807060T4 (en) | 2013-10-30 | 2018-06-21 | Kci Licensing Inc | Winding with different sizes of perforations. |
WO2015065616A1 (en) | 2013-10-30 | 2015-05-07 | Kci Licensing, Inc. | Dressing with sealing and retention intereface |
WO2015065615A1 (en) | 2013-10-30 | 2015-05-07 | Kci Licensing, Inc. | Absorbent conduit and system |
EP3848009A1 (en) | 2014-02-28 | 2021-07-14 | 3M Innovative Properties Company | Hybrid drape having a gel-coated perforated mesh |
US11026844B2 (en) | 2014-03-03 | 2021-06-08 | Kci Licensing, Inc. | Low profile flexible pressure transmission conduit |
EP3137029B1 (en) * | 2014-05-02 | 2020-09-09 | KCI Licensing, Inc. | Fluid storage devices, systems, and methods |
GB2526267B (en) * | 2014-05-14 | 2020-10-28 | Brightwake Ltd | Dressing for surgical drain |
EP3854361B8 (en) | 2014-06-05 | 2024-03-27 | Solventum Intellectual Properties Company | Dressing with fluid acquisition and distribution characteristics |
CA2952284C (en) | 2014-06-18 | 2023-03-28 | Smith & Nephew Plc | Wound dressing |
EP3023083A1 (en) * | 2014-11-20 | 2016-05-25 | Mölnlycke Health Care AB | Wound dressings |
US10398604B2 (en) | 2014-12-17 | 2019-09-03 | Kci Licensing, Inc. | Dressing with offloading capability |
AU2015370582B2 (en) | 2014-12-22 | 2020-07-02 | Smith & Nephew Plc | Negative pressure wound therapy apparatus and methods |
CA2975852A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
AU2016220059A1 (en) * | 2015-02-17 | 2017-09-14 | Sommetrics, Inc. | Medical pump filtration device, and methods of manufacture and use thereof |
US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
DK3288508T3 (en) * | 2015-04-27 | 2020-03-09 | Smith & Nephew | REDUCED PRESSURE DEVICES |
EP3294245B1 (en) | 2015-05-08 | 2019-09-04 | KCI Licensing, Inc. | Low acuity dressing with integral pump |
US10076594B2 (en) | 2015-05-18 | 2018-09-18 | Smith & Nephew Plc | Fluidic connector for negative pressure wound therapy |
US10166140B2 (en) * | 2015-06-25 | 2019-01-01 | Somnics, Inc. | Liquid container and absorbent insert for oral negative-pressure therapy system |
WO2017040045A1 (en) * | 2015-09-01 | 2017-03-09 | Kci Licensing, Inc. | Dressing with increased apposition force |
EP3892310A1 (en) | 2015-09-17 | 2021-10-13 | 3M Innovative Properties Co. | Hybrid silicone and acrylic adhesive cover for use with wound treatment |
US10844373B2 (en) | 2015-09-18 | 2020-11-24 | Twist Bioscience Corporation | Oligonucleic acid variant libraries and synthesis thereof |
KR20180058772A (en) | 2015-09-22 | 2018-06-01 | 트위스트 바이오사이언스 코포레이션 | Flexible substrate for nucleic acid synthesis |
AU2016343674C1 (en) | 2015-10-30 | 2021-06-10 | Aatru Medical, LLC | Wound therapy device and method |
US9895673B2 (en) | 2015-12-01 | 2018-02-20 | Twist Bioscience Corporation | Functionalized surfaces and preparation thereof |
EP3397220B1 (en) | 2015-12-30 | 2020-07-01 | Smith & Nephew plc | Negative pressure wound therapy apparatus |
US11090196B2 (en) | 2015-12-30 | 2021-08-17 | Smith & Nephew Plc | Absorbent negative pressure wound therapy dressing |
JP1586115S (en) | 2016-02-29 | 2017-09-19 | ||
USD796735S1 (en) | 2016-02-29 | 2017-09-05 | Smith & Nephew Plc | Mount apparatus for portable negative pressure apparatus |
CN109069708B (en) | 2016-03-04 | 2022-04-12 | 史密夫及内修公开有限公司 | Negative pressure wound therapy device for wounds after breast surgery |
CN114053031A (en) | 2016-03-07 | 2022-02-18 | 史密夫及内修公开有限公司 | Wound therapy apparatus and method utilizing a negative pressure source integrated into a wound dressing |
CN114469523A (en) | 2016-04-26 | 2022-05-13 | 史密夫及内修公开有限公司 | Wound dressing and method for use with an integrated negative pressure source having a fluid intrusion inhibiting feature |
EP3452129B1 (en) | 2016-05-03 | 2022-03-23 | Smith & Nephew plc | Negative pressure wound therapy device activation and control |
CA3022587A1 (en) | 2016-05-03 | 2017-11-09 | Smith & Nephew Plc | Systems and methods for driving negative pressure sources in negative pressure therapy systems |
AU2017259906B2 (en) * | 2016-05-03 | 2022-06-02 | Smith & Nephew Plc | Optimizing power transfer to negative pressure sources in negative pressure therapy systems |
GB201608099D0 (en) * | 2016-05-09 | 2016-06-22 | Convatec Technologies Inc | Negative pressure wound dressing |
KR20190028725A (en) | 2016-07-08 | 2019-03-19 | 컨바텍 테크놀러지스 인크 | Fluid Flow Detection |
MX2019000239A (en) | 2016-07-08 | 2019-09-06 | Convatec Technologies Inc | Flexible negative pressure system. |
TW201805036A (en) | 2016-07-08 | 2018-02-16 | 美商康瓦鐵克科技股份有限公司 | Fluid collection apparatus |
CA3034769A1 (en) | 2016-08-22 | 2018-03-01 | Twist Bioscience Corporation | De novo synthesized nucleic acid libraries |
AU2017315129B2 (en) | 2016-08-25 | 2022-10-27 | Smith & Nephew Plc | Absorbent negative pressure wound therapy dressing |
US10417457B2 (en) | 2016-09-21 | 2019-09-17 | Twist Bioscience Corporation | Nucleic acid based data storage |
EP3519001A1 (en) * | 2016-09-30 | 2019-08-07 | Smith & Nephew PLC | Negative pressure wound treatment apparatuses and methods with integrated electronics |
EP3551147B1 (en) | 2016-12-12 | 2023-08-09 | Smith & Nephew PLC | Wound dressing |
KR102514213B1 (en) | 2016-12-16 | 2023-03-27 | 트위스트 바이오사이언스 코포레이션 | Immune synaptic variant library and its synthesis |
EP3586255A4 (en) | 2017-02-22 | 2021-03-31 | Twist Bioscience Corporation | Nucleic acid based data storage |
CN110997028B (en) * | 2017-02-22 | 2022-12-30 | 康奈尔大学 | Mechanical vacuum dressing for mechanical management, protection and aspiration of small incision wounds |
JP7361606B2 (en) | 2017-03-08 | 2023-10-16 | スミス アンド ネフュー ピーエルシー | Control of negative pressure wound therapy devices in the presence of fault conditions |
CN110913865A (en) | 2017-03-15 | 2020-03-24 | 特韦斯特生物科学公司 | Library of variants of immune synapses and synthesis thereof |
US10583229B2 (en) * | 2017-04-04 | 2020-03-10 | Aatru Medical, LLC | Negative pressure device and method |
US10046095B1 (en) * | 2017-04-04 | 2018-08-14 | Aatru Medical, LLC | Wound therapy device and method |
SG11201910129SA (en) | 2017-05-09 | 2019-11-28 | Smith & Nephew | Redundant controls for negative pressure wound therapy systems |
SG11201912057RA (en) | 2017-06-12 | 2020-01-30 | Twist Bioscience Corp | Methods for seamless nucleic acid assembly |
WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
CA3065380A1 (en) * | 2017-06-14 | 2018-12-20 | T.J.Smith & Nephew, Limited | Negative pressure wound therapy apparatus |
GB201804502D0 (en) * | 2018-03-21 | 2018-05-02 | Smith & Nephew | Biocompatible encapsulation and component stress relief for sensor enabled negative pressure wound therapy dressings |
CN111566125A (en) | 2017-09-11 | 2020-08-21 | 特韦斯特生物科学公司 | GPCR binding proteins and synthesis thereof |
CN111065424A (en) * | 2017-09-13 | 2020-04-24 | 史密夫及内修公开有限公司 | Negative pressure wound therapy apparatus with integrated electronics and method |
GB201718070D0 (en) * | 2017-11-01 | 2017-12-13 | Smith & Nephew | Negative pressure wound treatment apparatuses and methods with integrated electronics |
US10894242B2 (en) | 2017-10-20 | 2021-01-19 | Twist Bioscience Corporation | Heated nanowells for polynucleotide synthesis |
EP3473218B1 (en) * | 2017-10-23 | 2021-09-01 | 3M Innovative Properties Company | Area management of tissue sites on articulating joints |
GB201718054D0 (en) * | 2017-11-01 | 2017-12-13 | Smith & Nephew | Sterilization of integrated negative pressure wound treatment apparatuses and sterilization methods |
GB201718072D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Negative pressure wound treatment apparatuses and methods with integrated electronics |
EP3703632B1 (en) * | 2017-11-01 | 2024-04-03 | Smith & Nephew plc | Negative pressure wound treatment apparatuses and methods with integrated electronics |
JP7424638B2 (en) | 2017-12-06 | 2024-01-30 | コーネル ユニヴァーシティー | Manually operated negative pressure wound therapy (NPWT) bandage with improved pump efficiency, automatic pressure indicator and automatic pressure limiter |
KR20200106067A (en) | 2018-01-04 | 2020-09-10 | 트위스트 바이오사이언스 코포레이션 | DNA-based digital information storage |
WO2019222706A1 (en) | 2018-05-18 | 2019-11-21 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
US20200038283A1 (en) * | 2018-08-01 | 2020-02-06 | Kci Licensing, Inc. | Soft-Tissue Treatment With Negative Pressure |
JP7383695B2 (en) * | 2018-08-29 | 2023-11-20 | アートラ・メディカル、エルエルシー | Negative pressure treatment with mechanical chemical pump |
USD898925S1 (en) | 2018-09-13 | 2020-10-13 | Smith & Nephew Plc | Medical dressing |
GB201900015D0 (en) * | 2019-01-02 | 2019-02-13 | Smith & Nephew | Negative pressure wound therapy apparatus |
CN113785057A (en) | 2019-02-26 | 2021-12-10 | 特韦斯特生物科学公司 | Variant nucleic acid libraries for antibody optimization |
CA3131689A1 (en) | 2019-02-26 | 2020-09-03 | Twist Bioscience Corporation | Variant nucleic acid libraries for glp1 receptor |
GB201903778D0 (en) * | 2019-03-20 | 2019-05-01 | Smith & Nephew | Exhaust blockage detection for negative pressure wound treatment apparatuses |
US11332738B2 (en) | 2019-06-21 | 2022-05-17 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
WO2021044309A1 (en) * | 2019-09-05 | 2021-03-11 | Kci Licensing, Inc. | Contoured dressing for tissue therapy |
US10828202B1 (en) | 2019-10-03 | 2020-11-10 | Aatru Medical, LLC | Negative pressure treatment including mechanical and chemical pump |
Family Cites Families (130)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1355846A (en) | 1920-02-06 | 1920-10-19 | David A Rannells | Medical appliance |
US2547758A (en) | 1949-01-05 | 1951-04-03 | Wilmer B Keeling | Instrument for treating the male urethra |
US2632443A (en) | 1949-04-18 | 1953-03-24 | Eleanor P Lesher | Surgical dressing |
GB692578A (en) | 1949-09-13 | 1953-06-10 | Minnesota Mining & Mfg | Improvements in or relating to drape sheets for surgical use |
US2682873A (en) | 1952-07-30 | 1954-07-06 | Johnson & Johnson | General purpose protective dressing |
NL189176B (en) | 1956-07-13 | 1900-01-01 | Hisamitsu Pharmaceutical Co | PLASTER BASED ON A SYNTHETIC RUBBER. |
US2969057A (en) | 1957-11-04 | 1961-01-24 | Brady Co W H | Nematodic swab |
US3066672A (en) | 1960-09-27 | 1962-12-04 | Jr William H Crosby | Method and apparatus for serial sampling of intestinal juice |
US3367332A (en) | 1965-08-27 | 1968-02-06 | Gen Electric | Product and process for establishing a sterile area of skin |
US3520300A (en) | 1967-03-15 | 1970-07-14 | Amp Inc | Surgical sponge and suction device |
US3568675A (en) | 1968-08-30 | 1971-03-09 | Clyde B Harvey | Fistula and penetrating wound dressing |
US3682180A (en) | 1970-06-08 | 1972-08-08 | Coilform Co Inc | Drain clip for surgical drain |
BE789293Q (en) | 1970-12-07 | 1973-01-15 | Parke Davis & Co | MEDICO-SURGICAL DRESSING FOR BURNS AND SIMILAR LESIONS |
US3826254A (en) | 1973-02-26 | 1974-07-30 | Verco Ind | Needle or catheter retaining appliance |
DE2527706A1 (en) | 1975-06-21 | 1976-12-30 | Hanfried Dr Med Weigand | DEVICE FOR THE INTRODUCTION OF CONTRAST AGENTS INTO AN ARTIFICIAL INTESTINAL OUTLET |
DE2640413C3 (en) | 1976-09-08 | 1980-03-27 | Richard Wolf Gmbh, 7134 Knittlingen | Catheter monitor |
NL7710909A (en) | 1976-10-08 | 1978-04-11 | Smith & Nephew | COMPOSITE STRAPS. |
GB1562244A (en) | 1976-11-11 | 1980-03-05 | Lock P M | Wound dressing materials |
US4080970A (en) | 1976-11-17 | 1978-03-28 | Miller Thomas J | Post-operative combination dressing and internal drain tube with external shield and tube connector |
US4139004A (en) | 1977-02-17 | 1979-02-13 | Gonzalez Jr Harry | Bandage apparatus for treating burns |
US4184510A (en) | 1977-03-15 | 1980-01-22 | Fibra-Sonics, Inc. | Valued device for controlling vacuum in surgery |
US4165748A (en) | 1977-11-07 | 1979-08-28 | Johnson Melissa C | Catheter tube holder |
US4256109A (en) | 1978-07-10 | 1981-03-17 | Nichols Robert L | Shut off valve for medical suction apparatus |
SE414994B (en) | 1978-11-28 | 1980-09-01 | Landstingens Inkopscentral | VENKATETERFORBAND |
GB2047543B (en) | 1978-12-06 | 1983-04-20 | Svedman Paul | Device for treating tissues for example skin |
US4266545A (en) | 1979-04-06 | 1981-05-12 | Moss James P | Portable suction device for collecting fluids from a closed wound |
US4284079A (en) | 1979-06-28 | 1981-08-18 | Adair Edwin Lloyd | Method for applying a male incontinence device |
US4261363A (en) | 1979-11-09 | 1981-04-14 | C. R. Bard, Inc. | Retention clips for body fluid drains |
US4569348A (en) | 1980-02-22 | 1986-02-11 | Velcro Usa Inc. | Catheter tube holder strap |
ATE14835T1 (en) | 1980-03-11 | 1985-08-15 | Schmid Eduard | SKIN GRAFT PRESSURE BANDAGE. |
US4297995A (en) | 1980-06-03 | 1981-11-03 | Key Pharmaceuticals, Inc. | Bandage containing attachment post |
US4333468A (en) | 1980-08-18 | 1982-06-08 | Geist Robert W | Mesentery tube holder apparatus |
US4465485A (en) | 1981-03-06 | 1984-08-14 | Becton, Dickinson And Company | Suction canister with unitary shut-off valve and filter features |
US4392853A (en) | 1981-03-16 | 1983-07-12 | Rudolph Muto | Sterile assembly for protecting and fastening an indwelling device |
US4373519A (en) | 1981-06-26 | 1983-02-15 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
US4392858A (en) | 1981-07-16 | 1983-07-12 | Sherwood Medical Company | Wound drainage device |
US4419097A (en) | 1981-07-31 | 1983-12-06 | Rexar Industries, Inc. | Attachment for catheter tube |
SE429197B (en) | 1981-10-14 | 1983-08-22 | Frese Nielsen | SAR TREATMENT DEVICE |
DE3146266A1 (en) | 1981-11-21 | 1983-06-01 | B. Braun Melsungen Ag, 3508 Melsungen | COMBINED DEVICE FOR A MEDICAL SUCTION DRAINAGE |
US4551139A (en) | 1982-02-08 | 1985-11-05 | Marion Laboratories, Inc. | Method and apparatus for burn wound treatment |
US4475909A (en) | 1982-05-06 | 1984-10-09 | Eisenberg Melvin I | Male urinary device and method for applying the device |
EP0100148B1 (en) | 1982-07-06 | 1986-01-08 | Dow Corning Limited | Medical-surgical dressing and a process for the production thereof |
NZ206837A (en) | 1983-01-27 | 1986-08-08 | Johnson & Johnson Prod Inc | Thin film adhesive dressing:backing material in three sections |
US4548202A (en) | 1983-06-20 | 1985-10-22 | Ethicon, Inc. | Mesh tissue fasteners |
US4540412A (en) | 1983-07-14 | 1985-09-10 | The Kendall Company | Device for moist heat therapy |
US4543100A (en) | 1983-11-01 | 1985-09-24 | Brodsky Stuart A | Catheter and drain tube retainer |
US4525374A (en) | 1984-02-27 | 1985-06-25 | Manresa, Inc. | Treating hydrophobic filters to render them hydrophilic |
GB2157958A (en) | 1984-05-03 | 1985-11-06 | Ernest Edward Austen Bedding | Ball game net support |
US4897081A (en) | 1984-05-25 | 1990-01-30 | Thermedics Inc. | Percutaneous access device |
US5215522A (en) | 1984-07-23 | 1993-06-01 | Ballard Medical Products | Single use medical aspirating device and method |
GB8419745D0 (en) | 1984-08-02 | 1984-09-05 | Smith & Nephew Ass | Wound dressing |
US4872450A (en) | 1984-08-17 | 1989-10-10 | Austad Eric D | Wound dressing and method of forming same |
US4655754A (en) | 1984-11-09 | 1987-04-07 | Stryker Corporation | Vacuum wound drainage system and lipids baffle therefor |
US4826494A (en) | 1984-11-09 | 1989-05-02 | Stryker Corporation | Vacuum wound drainage system |
US4605399A (en) | 1984-12-04 | 1986-08-12 | Complex, Inc. | Transdermal infusion device |
US5037397A (en) | 1985-05-03 | 1991-08-06 | Medical Distributors, Inc. | Universal clamp |
US4640688A (en) | 1985-08-23 | 1987-02-03 | Mentor Corporation | Urine collection catheter |
US4710165A (en) | 1985-09-16 | 1987-12-01 | Mcneil Charles B | Wearable, variable rate suction/collection device |
US4758220A (en) | 1985-09-26 | 1988-07-19 | Alcon Laboratories, Inc. | Surgical cassette proximity sensing and latching apparatus |
US4733659A (en) | 1986-01-17 | 1988-03-29 | Seton Company | Foam bandage |
WO1987004626A1 (en) | 1986-01-31 | 1987-08-13 | Osmond, Roger, L., W. | Suction system for wound and gastro-intestinal drainage |
US4838883A (en) | 1986-03-07 | 1989-06-13 | Nissho Corporation | Urine-collecting device |
JPS62281965A (en) | 1986-05-29 | 1987-12-07 | テルモ株式会社 | Catheter and catheter fixing member |
GB8621884D0 (en) | 1986-09-11 | 1986-10-15 | Bard Ltd | Catheter applicator |
GB2195255B (en) | 1986-09-30 | 1991-05-01 | Vacutec Uk Limited | Apparatus for vacuum treatment of an epidermal surface |
US4743232A (en) | 1986-10-06 | 1988-05-10 | The Clinipad Corporation | Package assembly for plastic film bandage |
DE3634569A1 (en) | 1986-10-10 | 1988-04-21 | Sachse Hans E | CONDOM CATHETER, A URINE TUBE CATHETER FOR PREVENTING RISING INFECTIONS |
JPS63135179A (en) | 1986-11-26 | 1988-06-07 | 立花 俊郎 | Subcataneous drug administration set |
GB8628564D0 (en) | 1986-11-28 | 1987-01-07 | Smiths Industries Plc | Anti-foaming agent suction apparatus |
GB8706116D0 (en) | 1987-03-14 | 1987-04-15 | Smith & Nephew Ass | Adhesive dressings |
US4787888A (en) | 1987-06-01 | 1988-11-29 | University Of Connecticut | Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a) |
US4863449A (en) | 1987-07-06 | 1989-09-05 | Hollister Incorporated | Adhesive-lined elastic condom cathether |
US5176663A (en) | 1987-12-02 | 1993-01-05 | Pal Svedman | Dressing having pad with compressibility limiting elements |
US4906240A (en) | 1988-02-01 | 1990-03-06 | Matrix Medica, Inc. | Adhesive-faced porous absorbent sheet and method of making same |
US4985019A (en) | 1988-03-11 | 1991-01-15 | Michelson Gary K | X-ray marker |
GB8812803D0 (en) | 1988-05-28 | 1988-06-29 | Smiths Industries Plc | Medico-surgical containers |
US4919654A (en) | 1988-08-03 | 1990-04-24 | Kalt Medical Corporation | IV clamp with membrane |
US5000741A (en) | 1988-08-22 | 1991-03-19 | Kalt Medical Corporation | Transparent tracheostomy tube dressing |
EP0379416B1 (en) | 1989-01-16 | 1995-03-08 | Roussel-Uclaf | Azabicycloheptene derivatives and their salts, process for their preparation, their use as medicaments and compositions containing them |
GB8906100D0 (en) | 1989-03-16 | 1989-04-26 | Smith & Nephew | Laminates |
US5261893A (en) | 1989-04-03 | 1993-11-16 | Zamierowski David S | Fastening system and method |
US5527293A (en) | 1989-04-03 | 1996-06-18 | Kinetic Concepts, Inc. | Fastening system and method |
US4969880A (en) | 1989-04-03 | 1990-11-13 | Zamierowski David S | Wound dressing and treatment method |
US5100396A (en) | 1989-04-03 | 1992-03-31 | Zamierowski David S | Fluidic connection system and method |
JP2719671B2 (en) | 1989-07-11 | 1998-02-25 | 日本ゼオン株式会社 | Wound dressing |
US5358494A (en) | 1989-07-11 | 1994-10-25 | Svedman Paul | Irrigation dressing |
US5232453A (en) | 1989-07-14 | 1993-08-03 | E. R. Squibb & Sons, Inc. | Catheter holder |
GB2235877A (en) | 1989-09-18 | 1991-03-20 | Antonio Talluri | Closed wound suction apparatus |
US5134994A (en) | 1990-02-12 | 1992-08-04 | Say Sam L | Field aspirator in a soft pack with externally mounted container |
US5092858A (en) | 1990-03-20 | 1992-03-03 | Becton, Dickinson And Company | Liquid gelling agent distributor device |
JP2941918B2 (en) | 1990-09-19 | 1999-08-30 | テルモ株式会社 | Weighing device |
US5149331A (en) | 1991-05-03 | 1992-09-22 | Ariel Ferdman | Method and device for wound closure |
EP0609236B1 (en) * | 1991-10-23 | 2002-05-02 | L.L.C. Patent Holdings | Wound dressing system |
US5278100A (en) | 1991-11-08 | 1994-01-11 | Micron Technology, Inc. | Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers |
US5645081A (en) | 1991-11-14 | 1997-07-08 | Wake Forest University | Method of treating tissue damage and apparatus for same |
US5636643A (en) | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
US5279550A (en) | 1991-12-19 | 1994-01-18 | Gish Biomedical, Inc. | Orthopedic autotransfusion system |
US5167613A (en) | 1992-03-23 | 1992-12-01 | The Kendall Company | Composite vented wound dressing |
FR2690617B1 (en) | 1992-04-29 | 1994-06-24 | Cbh Textile | TRANSPARENT ADHESIVE DRESSING. |
DE4306478A1 (en) | 1993-03-02 | 1994-09-08 | Wolfgang Dr Wagner | Drainage device, in particular pleural drainage device, and drainage method |
US5342376A (en) | 1993-05-03 | 1994-08-30 | Dermagraphics, Inc. | Inserting device for a barbed tissue connector |
US6241747B1 (en) | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
US5344415A (en) | 1993-06-15 | 1994-09-06 | Deroyal Industries, Inc. | Sterile system for dressing vascular access site |
US5437651A (en) | 1993-09-01 | 1995-08-01 | Research Medical, Inc. | Medical suction apparatus |
US5549584A (en) | 1994-02-14 | 1996-08-27 | The Kendall Company | Apparatus for removing fluid from a wound |
US5556375A (en) | 1994-06-16 | 1996-09-17 | Hercules Incorporated | Wound dressing having a fenestrated base layer |
US5607388A (en) | 1994-06-16 | 1997-03-04 | Hercules Incorporated | Multi-purpose wound dressing |
US5664270A (en) | 1994-07-19 | 1997-09-09 | Kinetic Concepts, Inc. | Patient interface system |
ES2223977T3 (en) | 1994-08-22 | 2005-03-01 | Kci Licensing, Inc. | CONTAINER. |
DE29504378U1 (en) | 1995-03-15 | 1995-09-14 | Mtg Medizinisch Tech Geraeteba | Electronically controlled low-vacuum pump for chest and wound drainage |
GB9523253D0 (en) | 1995-11-14 | 1996-01-17 | Mediscus Prod Ltd | Portable wound treatment apparatus |
US6135116A (en) | 1997-07-28 | 2000-10-24 | Kci Licensing, Inc. | Therapeutic method for treating ulcers |
AU755496B2 (en) | 1997-09-12 | 2002-12-12 | Kci Licensing, Inc. | Surgical drape and suction head for wound treatment |
GB9719520D0 (en) | 1997-09-12 | 1997-11-19 | Kci Medical Ltd | Surgical drape and suction heads for wound treatment |
US6071267A (en) | 1998-02-06 | 2000-06-06 | Kinetic Concepts, Inc. | Medical patient fluid management interface system and method |
US6488643B1 (en) | 1998-10-08 | 2002-12-03 | Kci Licensing, Inc. | Wound healing foot wrap |
US6287316B1 (en) | 1999-03-26 | 2001-09-11 | Ethicon, Inc. | Knitted surgical mesh |
US6856821B2 (en) | 2000-05-26 | 2005-02-15 | Kci Licensing, Inc. | System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure |
US7799004B2 (en) | 2001-03-05 | 2010-09-21 | Kci Licensing, Inc. | Negative pressure wound treatment apparatus and infection identification system and method |
US6991643B2 (en) | 2000-12-20 | 2006-01-31 | Usgi Medical Inc. | Multi-barbed device for retaining tissue in apposition and methods of use |
TR200401397T4 (en) | 2000-02-24 | 2004-07-21 | Venetec International, Inc. | Universal catheter insertion system. |
US6540705B2 (en) | 2001-02-22 | 2003-04-01 | Core Products International, Inc. | Ankle brace providing upper and lower ankle adjustment |
US7976519B2 (en) | 2002-12-31 | 2011-07-12 | Kci Licensing, Inc. | Externally-applied patient interface system and method |
US9259175B2 (en) * | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
GB0508194D0 (en) | 2005-04-22 | 2005-06-01 | The Technology Partnership Plc | Pump |
EP3360519B1 (en) * | 2007-11-21 | 2020-11-18 | Smith & Nephew plc | Wound dressing |
EP3409304B1 (en) | 2008-03-05 | 2022-07-27 | 3M Innovative Properties Company | Dressing for applying reduced pressure to and collecting and storing fluid from a tissue site |
CN102143726B (en) * | 2008-09-18 | 2015-03-18 | 凯希特许有限公司 | Multi-layer dressings, systems, and methods for applying reduced pressure at a tissue site |
JP6034547B2 (en) | 2010-09-03 | 2016-11-30 | 凸版印刷株式会社 | Lid for sealing the container |
US8579872B2 (en) | 2010-10-27 | 2013-11-12 | Kci Licensing, Inc. | Reduced-pressure systems, dressings, and methods employing a wireless pump |
-
2013
- 2013-03-28 US US14/386,444 patent/US10286129B2/en not_active Expired - Fee Related
- 2013-03-28 CN CN201380012153.1A patent/CN104168865B/en not_active Expired - Fee Related
- 2013-03-28 EP EP13716656.7A patent/EP2830555B1/en not_active Not-in-force
- 2013-03-28 CA CA2864428A patent/CA2864428A1/en not_active Abandoned
- 2013-03-28 AU AU2013237989A patent/AU2013237989B2/en not_active Ceased
- 2013-03-28 WO PCT/US2013/034472 patent/WO2013149078A1/en active Application Filing
- 2013-03-28 JP JP2015503614A patent/JP6238417B2/en not_active Expired - Fee Related
-
2019
- 2019-03-28 US US16/367,600 patent/US20190262514A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022271449A1 (en) * | 2021-06-25 | 2022-12-29 | Aatru Medical, LLC | Dressing having metal coating |
Also Published As
Publication number | Publication date |
---|---|
JP2015516197A (en) | 2015-06-11 |
JP6238417B2 (en) | 2017-11-29 |
EP2830555B1 (en) | 2017-08-02 |
CN104168865A (en) | 2014-11-26 |
CN104168865B (en) | 2016-10-26 |
AU2013237989B2 (en) | 2017-07-20 |
WO2013149078A1 (en) | 2013-10-03 |
CA2864428A1 (en) | 2013-10-03 |
US10286129B2 (en) | 2019-05-14 |
EP2830555A1 (en) | 2015-02-04 |
US20150057625A1 (en) | 2015-02-26 |
AU2013237989A1 (en) | 2014-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190262514A1 (en) | Reduced-Pressure Systems, Dressings, And Methods Facilitating Separation Of Electronic And Clinical Component Parts | |
US20180021178A1 (en) | Reduced-Pressure Systems, Dressings, Pump Assemblies And Methods | |
US20200129675A1 (en) | Reduced-pressure dressing connection pads, systems, and methods | |
US9265867B2 (en) | Reduced-pressure systems, dressings, and methods employing a wireless pump | |
US9474836B2 (en) | Reduced-pressure canisters and methods for recycling | |
US8663132B2 (en) | Reduced-pressure treatment systems and methods employing a variable cover | |
EP2790623B1 (en) | Sealing systems and methods employing a switchable drape | |
EP3421020B1 (en) | Reduced-pressure, wound-treatment dressings | |
EP3072542B1 (en) | Reduced-pressure sources and systems employing a polymeric, porous, hydrophobic material | |
EP2801380B1 (en) | Reduced-pressure dressings having desolidifying barrier layers | |
US10293088B2 (en) | Reduced-pressure systems and methods employing an ultraviolet light source for reducing bioburden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: KCI LICENSING, INC., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:COULTHARD, RICHARD DANIEL JOHN;REEL/FRAME:052463/0714 Effective date: 20130326 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |